Disruption	O
of	O
alpha	O
beta	O
but	O
not	O
of	O
gamma	O
delta	O
T	O
cell	O
development	O
by	O
overexpression	O
of	O
the	O
helix-loop-helix	B-protein
protein	I-protein
Id3	B-protein
in	O
committed	B-cell_type
T	I-cell_type
cell	I-cell_type
progenitors	I-cell_type
.	O

Enforced	O
expression	O
of	O
Id3	B-protein
,	O
which	O
has	O
the	O
capacity	O
to	O
inhibit	O
many	O
basic	B-protein
helix-loop-helix	I-protein
(	I-protein
bHLH	I-protein
)	I-protein
transcription	I-protein
factors	I-protein
,	O
in	O
human	B-cell_type
CD34	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
hematopoietic	I-cell_type
progenitor	I-cell_type
cells	I-cell_type
that	O
have	O
not	O
undergone	O
T	B-DNA
cell	I-DNA
receptor	I-DNA
(	I-DNA
TCR	I-DNA
)	I-DNA
gene	I-DNA
rearrangements	I-DNA
inhibits	O
development	O
of	O
the	O
transduced	B-cell_type
cells	I-cell_type
into	O
TCRalpha	B-cell_line
beta	I-cell_line
and	I-cell_line
gamma	I-cell_line
delta	I-cell_line
cells	I-cell_line
in	O
a	O
fetal	B-cell_line
thymic	I-cell_line
organ	I-cell_line
culture	I-cell_line
(	O
FTOC	B-cell_line
)	O
.	O

Here	O
we	O
document	O
that	O
overexpression	O
of	O
Id3	B-protein
,	O
in	O
progenitors	B-cell_type
that	O
have	O
initiated	O
TCR	B-DNA
gene	I-DNA
rearrangements	I-DNA
(	O
pre-T	B-cell_type
cells	I-cell_type
)	O
,	O
inhibits	O
development	O
into	O
TCRalpha	B-cell_line
beta	I-cell_line
but	O
not	O
into	O
TCRgamma	B-cell_line
delta	I-cell_line
T	I-cell_line
cells	I-cell_line
.	O

Furthermore	O
,	O
Id3	B-protein
impedes	O
expression	O
of	O
recombination	O
activating	O
genes	O
and	O
downregulates	O
pre-Talpha	B-RNA
mRNA	I-RNA
.	O

These	O
observations	O
suggest	O
possible	O
mechanisms	O
by	O
which	O
Id3	B-protein
overexpression	O
can	O
differentially	O
affect	O
development	O
of	O
pre-T	B-cell_type
cells	I-cell_type
into	O
TCRalpha	B-cell_line
beta	I-cell_line
and	I-cell_line
gamma	I-cell_line
delta	I-cell_line
cells	I-cell_line
.	O

We	O
also	O
observed	O
that	O
cell	B-cell_type
surface	I-cell_type
CD4	I-cell_type
(	I-cell_type
-	I-cell_type
)	I-cell_type
CD8	I-cell_type
(	I-cell_type
-	I-cell_type
)	I-cell_type
CD3	I-cell_type
(	I-cell_type
-	I-cell_type
)	I-cell_type
cells	I-cell_type
with	O
rearranged	B-DNA
TCR	I-DNA
genes	I-DNA
developed	O
from	O
Id3-transduced	B-cell_line
but	O
not	O
from	O
control-transduced	B-cell_line
pre-T	I-cell_line
cells	I-cell_line
in	O
an	O
FTOC	B-cell_line
.	O

These	O
cells	O
had	O
properties	O
of	O
both	O
natural	B-cell_type
killer	I-cell_type
(	O
NK	B-cell_type
)	O
and	O
pre-T	B-cell_type
cells	I-cell_type
.	O

These	O
findings	O
suggest	O
that	O
bHLH	B-protein
factors	I-protein
are	O
required	O
to	O
control	O
T	O
cell	O
development	O
after	O
the	O
T/NK	O
developmental	O
checkpoint	O
.	O

The	NULL
EMBO	NULL
Journal	NULL
Vol.18	NULL
No.10	NULL
pp.2793-2802	NULL
,	NULL
1999	NULL
Disruption	NULL
of	NULL
aB	NULL
but	NULL
not	NULL
of	NULL
yo	NULL
T	NULL
cell	NULL
development	NULL
by	NULL
overexpression	NULL
of	NULL
the	NULL
helix-loop-helix	NULL
protein	NULL
Id3	NULL
in	NULL
committed	NULL
T	NULL
cell	NULL
progenitors	NULL
Bianca	NULL
Blom	NULL
,	NULL
Mirjam	NULL
H.M.Heemskerk	NULL
,	NULL
Martie	NULL
C.M.Verschuren	NULL
'	NULL
,	NULL
Jacques	NULL
J.M.van	NULL
Dongen	NULL
,	NULL
Alexander	NULL
P.A.Stegmann	NULL
,	NULL
Arjen	NULL
Q.Bakker	NULL
,	NULL
Franka	NULL
Couwenberg	NULL
,	NULL
Pieter	NULL
C.M.Res	NULL
and	NULL
Hergen	NULL
Spits*	NULL
Division	NULL
of	NULL
Immunology	NULL
,	NULL
The	NULL
Netherlands	NULL
Cancer	NULL
Institute	NULL
,	NULL
Antoni	NULL
van	NULL
Leeuwenhoek	NULL
Huis	NULL
,	NULL
Plesmanlaan	NULL
121	NULL
,	NULL
1066	NULL
CX	NULL
Amsterdam	NULL
and	NULL
'Department	NULL
of	NULL
Immunology	NULL
,	NULL
Erasmus	NULL
University	NULL
Rotterdam	NULL
and	NULL
University	NULL
Hospital	NULL
Rotterdam	NULL
,	NULL
Rotterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
Corresponding	NULL
author	NULL
e-mail	NULL
:	NULL
hergen	NULL
@	NULL
nki.ol	NULL
Enforced	NULL
expression	NULL
of	NULL
Id3	NULL
,	NULL
which	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
inhibit	NULL
many	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
)	NULL
transcription	NULL
factors	NULL
,	NULL
in	NULL
human	NULL
CD34*	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
that	NULL
have	NULL
not	NULL
undergone	NULL
T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
gene	NULL
rearrangements	NULL
inhibits	NULL
development	NULL
of	NULL
the	NULL
transduced	NULL
cells	NULL
into	NULL
TCR	NULL
@	NULL
RB	NULL
and	NULL
45	NULL
cells	NULL
in	NULL
a	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
(	NULL
FTOC	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
document	NULL
that	NULL
overexpression	NULL
of	NULL
Id3	NULL
,	NULL
in	NULL
progenitors	NULL
that	NULL
have	NULL
initiated	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
(	NULL
pre-T	NULL
cells	NULL
)	NULL
,	NULL
inhibits	NULL
development	NULL
into	NULL
TCRa	NULL
&	NULL
RB	NULL
but	NULL
not	NULL
into	NULL
TCRy8	NULL
T	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
Id3	NULL
impedes	NULL
expression	NULL
of	NULL
recombination	NULL
activating	NULL
genes	NULL
and	NULL
downregulates	NULL
pre-TG	NULL
mRNA	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
possible	NULL
mechanisms	NULL
by	NULL
which	NULL
Id3	NULL
overexpression	NULL
can	NULL
differentially	NULL
affect	NULL
development	NULL
of	NULL
pre-T	NULL
cells	NULL
into	NULL
TCRB	NULL
and	NULL
46	NULL
cells	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
that	NULL
cell	NULL
surface	NULL
CD4-CDS8-CD3~	NULL
cells	NULL
with	NULL
rearranged	NULL
TCR	NULL
genes	NULL
developed	NULL
from	NULL
1Id3-transduced	NULL
but	NULL
not	NULL
from	NULL
control-transduced	NULL
pre-	NULL
T	NULL
cells	NULL
in	NULL
an	NULL
FTOC	NULL
.	NULL

These	NULL
cells	NULL
had	NULL
properties	NULL
of	NULL
both	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
and	NULL
pre-T	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
bHLH	NULL
factors	NULL
are	NULL
required	NULL
to	NULL
control	NULL
T	NULL
cell	NULL
development	NULL
after	NULL
the	NULL
T/NK	NULL
developmental	NULL
checkpoint	NULL
.	NULL

Keywords	NULL
:	NULL
basic	NULL
helix-loop-helix	NULL
protein/NK	NULL
cell/T	NULL
cells/thymus/transcription	NULL
Introduction	NULL
During	NULL
the	NULL
period	NULL
of	NULL
T	NULL
cell	NULL
differentiation	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
there	NULL
is	NULL
a	NULL
continuous	NULL
influx	NULL
of	NULL
blood-borne	NULL
hematopoietic	NULL
progenitors	NULL
(	NULL
Scollay	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Donskoy	NULL
and	NULL
Goldschneider	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

While	NULL
the	NULL
exact	NULL
identity	NULL
of	NULL
the	NULL
thymic	NULL
immigrants	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
,	NULL
studies	NULL
on	NULL
the	NULL
most	NULL
primitive	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
in	NULL
both	NULL
human	NULL
and	NULL
mouse	NULL
thymus	NULL
strongly	NULL
suggest	NULL
that	NULL
these	NULL
cells	NULL
are	NULL
not	NULL
committed	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
(	NULL
Spits	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Shortman	NULL
and	NULL
Wu	NULL
,	NULL
1996	NULL
;	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
earliest	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
in	NULL
the	NULL
human	NULL
thymus	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
CD34	NULL
,	NULL
lack	NULL
CD1a	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
and	NULL
have	NULL
the	NULL
capacity	NULL
to	NULL
develop	NULL
into	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
Â©	NULL
European	NULL
Molecular	NULL
Biology	NULL
Organization	NULL
and	NULL
dendritic	NULL
cells	NULL
(	NULL
Sanchez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Marquez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Res	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

CD1a-CD34*	NULL
cells	NULL
have	NULL
their	NULL
y	NULL
genes	NULL
in	NULL
the	NULL
germline	NULL
configuration	NULL
but	NULL
contain	NULL
immature	NULL
(	NULL
D-D	NULL
and	NULL
D-J	NULL
)	NULL
T	NULL
cell	NULL
receptor	NULL
8	NULL
(	NULL
TCR8	NULL
)	NULL
gene	NULL
rearrangements	NULL
(	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Upregulation	NULL
of	NULL
CD1a	NULL
on	NULL
CD34	NULL
*	NULL
cells	NULL
is	NULL
correlated	NULL
with	NULL
induction	NULL
of	NULL
T	NULL
cell	NULL
commitment	NULL
as	NULL
mature	NULL
TCRS	NULL
rearrangements	NULL
are	NULL
present	NULL
and	NULL
TCRy	NULL
and	NULL
TCRB	NULL
rearrangements	NULL
commence	NULL
at	NULL
the	NULL
CD1atCD34+*	NULL
stage	NULL
(	NULL
Ramiro	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
,	NULL
1999	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
develop	NULL
into	NULL
CD3-CD4*CD8~	NULL
,	NULL
denoted	NULL
CD4	NULL
immature	NULL
single	NULL
positive	NULL
(	NULL
ISP	NULL
)	NULL
,	NULL
cells	NULL
(	NULL
Galy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Kraft	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

CD4	NULL
ISP	NULL
cells	NULL
are	NULL
fully	NULL
committed	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
as	NULL
they	NULL
are	NULL
unable	NULL
to	NULL
differentiate	NULL
into	NULL
cells	NULL
other	NULL
than	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
great	NULL
majority	NULL
if	NULL
not	NULL
all	NULL
of	NULL
the	NULL
CD4	NULL
ISP	NULL
cells	NULL
contain	NULL
mature	NULL
TCR8	NULL
rearrangements	NULL
,	NULL
and	NULL
~35	NULL
%	NULL
of	NULL
the	NULL
TCRy	NULL
alleles	NULL
are	NULL
rearranged	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
TCRRB	NULL
alleles	NULL
(	NULL
85	NULL
%	NULL
)	NULL
of	NULL
the	NULL
CD4	NULL
ISP	NULL
cells	NULL
are	NULL
still	NULL
in	NULL
the	NULL
germlike	NULL
configuration	NULL
(	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

The	NULL
hierarchy	NULL
in	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
found	NULL
by	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

is	NULL
consistent	NULL
with	NULL
a	NULL
recent	NULL
analysis	NULL
of	NULL
in-	NULL
and	NULL
out-of-frame	NULL
and	NULL
8	NULL
rearrangements	NULL
,	NULL
indicating	NULL
that	NULL
in	NULL
most	NULL
humans	NULL
the	NULL
TCR8	NULL
locus	NULL
rearranges	NULL
before	NULL
B	NULL
(	NULL
Margolis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
latter	NULL
study	NULL
also	NULL
suggested	NULL
that	NULL
in	NULL
some	NULL
individuals	NULL
the	NULL
TCRS	NULL
locus	NULL
rearranges	NULL
concurrently	NULL
with	NULL
TCRB	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
various	NULL
developmental	NULL
cellular	NULL
stages	NULL
and	NULL
the	NULL
hierarchy	NULL
of	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
during	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
man	NULL
and	NULL
mice	NULL
are	NULL
similar	NULL
(	NULL
Shortman	NULL
and	NULL
Wu	NULL
,	NULL
1996	NULL
;	NULL
Capone	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Spits	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

When	NULL
developing	NULL
into	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
progenitor	NULL
cells	NULL
should	NULL
pass	NULL
a	NULL
number	NULL
of	NULL
clearly	NULL
defined	NULL
checkpoints	NULL
(	NULL
Godfrey	NULL
and	NULL
Zlotnik	NULL
,	NULL
1993	NULL
;	NULL
Shortman	NULL
and	NULL
Wu	NULL
,	NULL
1996	NULL
;	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
first	NULL
one	NULL
is	NULL
the	NULL
T/NK	NULL
checkpoint	NULL
when	NULL
progenitor	NULL
cells	NULL
commit	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
.	NULL

This	NULL
should	NULL
occur	NULL
at	NULL
or	NULL
around	NULL
the	NULL
transition	NULL
of	NULL
CD1a	NULL
CD34*	NULL
into	NULL
CD1atCD34Â¢*	NULL
cells	NULL
.	NULL

A	NULL
second	NULL
checkpoint	NULL
is	NULL
when	NULL
the	NULL
pre-T	NULL
cell	NULL
chooses	NULL
to	NULL
become	NULL
either	NULL
a	NULL
TCR	NULL
Â«	NULL
RB	NULL
or	NULL
a	NULL
TCRY8	NULL
cell	NULL
;	NULL
the	NULL
cellular	NULL
stage	NULL
where	NULL
this	NULL
happens	NULL
in	NULL
the	NULL
human	NULL
thymus	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

The	NULL
mechanisms	NULL
of	NULL
the	NULL
T/NK	NULL
and	NULL
TCR	NULL
Â«	NULL
B/yd	NULL
lineage	NULL
choices	NULL
are	NULL
as	NULL
yet	NULL
poorly	NULL
understood	NULL
.	NULL

Recent	NULL
studies	NULL
in	NULL
mouse	NULL
and	NULL
human	NULL
systems	NULL
have	NULL
provided	NULL
evidence	NULL
that	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
)	NULL
transcription	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
induction	NULL
of	NULL
commitment	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
at	NULL
the	NULL
T/NK	NULL
checkpoint	NULL
(	NULL
Bain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997a	NULL
;	NULL
Heemskerk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

bHLH	NULL
factors	NULL
are	NULL
well	NULL
characterized	NULL
and	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
regulators	NULL
of	NULL
lineage	NULL
determination	NULL
and	NULL
cell	NULL
type	NULL
specification	NULL
in	NULL
many	NULL
organisms	NULL
(	NULL
Murre	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
are	NULL
characterized	NULL
by	NULL
two	NULL
highly	NULL
conserved	NULL
bipartite	NULL
domains	NULL
.	NULL

An	NULL
HLH	NULL
domain	NULL
,	NULL
mainly	NULL
consisting	NULL
of	NULL
hydrophobic	NULL
residues	NULL
,	NULL
permits	NULL
hetero-	NULL
or	NULL
homodimerization	NULL
of	NULL
these	NULL
proteins	NULL
.	NULL

A	NULL
motif	NULL
of	NULL
basic	NULL
residues	NULL
mediates	NULL
binding	NULL
of	NULL
these	NULL
complexes	NULL
to	NULL
a	NULL
con	NULL
2793	NULL
B.Blom	NULL
et	NULL
al	NULL
.	NULL

xc	NULL
%	NULL
@	NULL
:	NULL
-L	NULL
#	NULL
/	NULL
A	NULL
@	NULL
Â»	NULL
/o	NULL
Â»	NULL
@	NULL
+	NULL
@	NULL
+	NULL
C	NULL
multipotent	NULL
T/NK	NULL
pre-T	NULL
Pre-T	NULL
(	NULL
CD4	NULL
ISP	NULL
)	NULL
_	NULL
DP	NULL
3M+1a5	NULL
34+1a-5+	NULL
34+iat5+	NULL
lat5+4+8~	NULL
lat5+4+8~	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

A	NULL
model	NULL
of	NULL
early	NULL
developmental	NULL
stages	NULL
of	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
the	NULL
human	NULL
thymus	NULL
.	NULL

sensus	NULL
E-box	NULL
(	NULL
CANNTG	NULL
)	NULL
sequence	NULL
present	NULL
in	NULL
promoters	NULL
or	NULL
enhancers	NULL
of	NULL
target	NULL
genes	NULL
(	NULL
Church	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Ephrussi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
.	NULL

Two	NULL
members	NULL
of	NULL
the	NULL
bHLH	NULL
family	NULL
,	NULL
E12	NULL
and	NULL
E47	NULL
,	NULL
encoded	NULL
by	NULL
the	NULL
E2A	NULL
gene	NULL
(	NULL
Murre	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
are	NULL
essential	NULL
for	NULL
B	NULL
cell	NULL
development	NULL
but	NULL
are	NULL
also	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
(	NULL
Bain	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
,	NULL
1997a	NULL
,	NULL
b	NULL
;	NULL
Zhuang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
thymuses	NULL
of	NULL
E2A-deficient	NULL
mice	NULL
have	NULL
a	NULL
low	NULL
cellularity	NULL
with	NULL
a	NULL
size	NULL
of	NULL
~20	NULL
%	NULL
compared	NULL
with	NULL
their	NULL
wild-type	NULL
littermates	NULL
.	NULL

T	NULL
cell	NULL
differentiation	NULL
is	NULL
partially	NULL
blocked	NULL
at	NULL
an	NULL
early	NULL
stage	NULL
of	NULL
development	NULL
.	NULL

Mice	NULL
deficient	NULL
for	NULL
another	NULL
bHLH	NULL
factor	NULL
,	NULL
HEB	NULL
,	NULL
exhibit	NULL
,	NULL
besides	NULL
a	NULL
profound	NULL
B	NULL
cell	NULL
defect	NULL
,	NULL
a	NULL
partial	NULL
T	NULL
cell	NULL
developmental	NULL
block	NULL
(	NULL
Zhuang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Concordant	NULL
with	NULL
these	NULL
observations	NULL
in	NULL
the	NULL
mouse	NULL
,	NULL
we	NULL
have	NULL
documented	NULL
that	NULL
inhibition	NULL
of	NULL
bHLH	NULL
factors	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
precursors	NULL
blocks	NULL
development	NULL
of	NULL
these	NULL
cells	NULL
into	NULL
T	NULL
cells	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
(	NULL
FTOC	NULL
)	NULL
(	NULL
Heemskerk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
that	NULL
study	NULL
,	NULL
we	NULL
took	NULL
advantage	NULL
of	NULL
the	NULL
finding	NULL
that	NULL
transcriptional	NULL
activity	NULL
of	NULL
bHLH	NULL
factors	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
structurally	NULL
related	NULL
group	NULL
of	NULL
proteins	NULL
,	NULL
generally	NULL
referred	NULL
to	NULL
as	NULL
inhibitors	NULL
of	NULL
DNA	NULL
binding	NULL
or	NULL
Id	NULL
proteins	NULL
.	NULL

This	NULL
subfamily	NULL
consists	NULL
of	NULL
four	NULL
members	NULL
(	NULL
Id1-Id4	NULL
)	NULL
that	NULL
have	NULL
varying	NULL
tissue	NULL
distributions	NULL
(	NULL
Christy	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Riechmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Id	NULL
proteins	NULL
possess	NULL
the	NULL
protein	NULL
dimerization	NULL
HLH	NULL
domain	NULL
,	NULL
resulting	NULL
in	NULL
an	NULL
ability	NULL
to	NULL
heterodimerize	NULL
with	NULL
the	NULL
bHLH	NULL
proteins	NULL
,	NULL
but	NULL
as	NULL
they	NULL
lack	NULL
the	NULL
basic	NULL
motif	NULL
,	NULL
they	NULL
can	NULL
not	NULL
bind	NULL
DNA	NULL
.	NULL

Id	NULL
proteins	NULL
block	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
bHLH	NULL
proteins	NULL
by	NULL
sequestering	NULL
these	NULL
factors	NULL
(	NULL
Benezra	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
exogenous	NULL
expression	NULL
of	NULL
one	NULL
of	NULL
the	NULL
Id	NULL
proteins	NULL
,	NULL
Id3	NULL
,	NULL
following	NULL
retrovirus-mediated	NULL
gene	NULL
transfer	NULL
in	NULL
human	NULL
CD34*	NULL
fetal	NULL
liver	NULL
and	NULL
thymocyte	NULL
populations	NULL
,	NULL
inhibits	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
an	NULL
FTOC	NULL
exactly	NULL
at	NULL
the	NULL
T/NK	NULL
branch	NULL
point	NULL
(	NULL
Heemskerk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Most	NULL
interestingly	NULL
,	NULL
NK	NULL
cell	NULL
development	NULL
was	NULL
promoted	NULL
by	NULL
enforced	NULL
expression	NULL
of	NULL
Id3	NULL
,	NULL
suggesting	NULL
that	NULL
sequestration	NULL
of	NULL
bHLH	NULL
factors	NULL
results	NULL
in	NULL
a	NULL
shift	NULL
in	NULL
cell	NULL
fate	NULL
from	NULL
T	NULL
to	NULL
NK	NULL
lineage	NULL
cells	NULL
.	NULL

As	NULL
Id3	NULL
interacts	NULL
with	NULL
EZA	NULL
and	NULL
HEB	NULL
proteins	NULL
,	NULL
preventing	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
by	NULL
these	NULL
proteins	NULL
(	NULL
Loveys	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
our	NULL
findings	NULL
have	NULL
established	NULL
an	NULL
important	NULL
role	NULL
of	NULL
bHLH	NULL
factors	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

The	NULL
transcriptional	NULL
control	NULL
mechanisms	NULL
that	NULL
dictate	NULL
the	NULL
Â«	NULL
B/y5	NULL
lineage	NULL
decision	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
elucidated	NULL
.	NULL

However	NULL
,	NULL
some	NULL
of	NULL
the	NULL
factors	NULL
that	NULL
contribute	NULL
to	NULL
the	NULL
divergence	NULL
of	NULL
Â«	NULL
B/y8	NULL
lineage	NULL
have	NULL
been	NULL
resolved	NULL
using	NULL
the	NULL
mouse	NULL
system	NULL
.	NULL

The	NULL
occurrence	NULL
of	NULL
productive	NULL
rearrangements	NULL
at	NULL
the	NULL
y	NULL
and	NULL
8	NULL
loci	NULL
(	NULL
Kang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Livak	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
is	NULL
an	NULL
important	NULL
factor	NULL
,	NULL
but	NULL
also	NULL
external	NULL
signals	NULL
provided	NULL
through	NULL
Notch1	NULL
(	NULL
Washburn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
and	NULL
the	NULL
pre-TCR	NULL
(	NULL
Aifantis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
have	NULL
been	NULL
implicated	NULL
.	NULL

2794	NULL
Here	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
bHLH	NULL
factors	NULL
,	NULL
besides	NULL
their	NULL
role	NULL
in	NULL
the	NULL
T/NK	NULL
lineage	NULL
determination	NULL
,	NULL
differentially	NULL
affect	NULL
TCRa	NULL
@	NULL
B/y8	NULL
lineage	NULL
development	NULL
in	NULL
an	NULL
FTOC	NULL
beyond	NULL
the	NULL
T/NK	NULL
checkpoint	NULL
.	NULL

We	NULL
took	NULL
advantage	NULL
of	NULL
a	NULL
retroviral	NULL
system	NULL
that	NULL
allows	NULL
introduction	NULL
of	NULL
genes	NULL
into	NULL
cells	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
development	NULL
to	NULL
express	NULL
Id3	NULL
in	NULL
CD1a*CD34*	NULL
and	NULL
CD4	NULL
ISP	NULL
pre-T	NULL
cells	NULL
.	NULL

It	NULL
was	NULL
observed	NULL
that	NULL
development	NULL
of	NULL
the	NULL
transduced	NULL
cells	NULL
into	NULL
TCRaR	NULL
cells	NULL
was	NULL
strongly	NULL
blocked	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
development	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
TCRYy8	NULL
T	NULL
cells	NULL
was	NULL
not	NULL
inhibited	NULL
.	NULL

Strikingly	NULL
,	NULL
Id3-transduced	NULL
but	NULL
not	NULL
control-transduced	NULL
CD4	NULL
ISP	NULL
cells	NULL
have	NULL
the	NULL
capacity	NULL
to	NULL
develop	NULL
into	NULL
CD3~	NULL
cells	NULL
that	NULL
lost	NULL
CD1a	NULL
and	NULL
CD4	NULL
expression	NULL
but	NULL
retained	NULL
rearranged	NULL
TCR	NULL
genes	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
continued	NULL
activities	NULL
of	NULL
bHLH	NULL
factors	NULL
are	NULL
required	NULL
to	NULL
control	NULL
development	NULL
of	NULL
TCRaRB	NULL
cells	NULL
beyond	NULL
the	NULL
T/NK	NULL
checkpoint	NULL
.	NULL

Results	NULL
Effect	NULL
of	NULL
constitutive	NULL
Id3	NULL
expression	NULL
on	NULL
development	NULL
of	NULL
CD1a*	NULL
CD34*	NULL
thymocytes	NULL
in	NULL
an	NULL
FTOC	NULL
We	NULL
observed	NULL
previously	NULL
that	NULL
overexpression	NULL
of	NULL
Id3	NULL
in	NULL
CD1a-CD34*	NULL
cells	NULL
results	NULL
in	NULL
inhibition	NULL
of	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
into	NULL
CD1at*	NULL
cells	NULL
and	NULL
stimulation	NULL
of	NULL
NK	NULL
development	NULL
(	NULL
Heemskerk	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
Id3	NULL
prevented	NULL
initiation	NULL
of	NULL
TCRB	NULL
gene	NULL
rearrangements	NULL
in	NULL
CD1a-CD34+*	NULL
thymocytes	NULL
cultured	NULL
in	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-7	NULL
.	NULL

Our	NULL
results	NULL
indicated	NULL
that	NULL
sequestering	NULL
of	NULL
bHLH	NULL
factors	NULL
by	NULL
Id3	NULL
inhibits	NULL
transition	NULL
of	NULL
CD1a~	NULL
into	NULL
CD1a*	NULL
progenitor	NULL
cells	NULL
.	NULL

As	NULL
the	NULL
NK	NULL
precursor	NULL
cell	NULL
activity	NULL
is	NULL
strongly	NULL
reduced	NULL
in	NULL
CD1atCD34+*	NULL
thymocytes	NULL
(	NULL
Spits	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
and	NULL
TCRy	NULL
and	NULL
B	NULL
gene	NULL
rearrangements	NULL
are	NULL
initiated	NULL
upon	NULL
upregulation	NULL
of	NULL
CD1la	NULL
(	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
,	NULL
it	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
bHLH	NULL
factors	NULL
are	NULL
necessary	NULL
after	NULL
acquisition	NULL
of	NULL
CD1la	NULL
.	NULL

We	NULL
sorted	NULL
thymocytes	NULL
and	NULL
transduced	NULL
them	NULL
with	NULL
Id3-internal	NULL
ribo-some	NULL
entry	NULL
site	NULL
(	NULL
IRES	NULL
)	NULL
-green	NULL
fluorescent	NULL
protein	NULL
(	NULL
GFP	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
an	NULL
FTOC	NULL
for	NULL
3	NULL
weeks	NULL
.	NULL

In	NULL
a	NULL
representative	NULL
experiment	NULL
,	NULL
1.6	NULL
X	NULL
10Â°	NULL
cells	NULL
were	NULL
recovered	NULL
,	NULL
of	NULL
which	NULL
3	NULL
%	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
GFP	NULL
marker	NULL
,	NULL
from	NULL
five	NULL
lobes	NULL
which	NULL
initially	NULL
were	NULL
seeded	NULL
with	NULL
40	NULL
000	NULL
cells/lobe	NULL
(	NULL
8-fold	NULL
expansion	NULL
)	NULL
.	NULL

The	NULL
phenotypic	NULL
analysis	NULL
of	NULL
these	NULL
cells	NULL
is	NULL
shown	NULL
in	NULL
Figure	NULL
2	NULL
.	NULL

The	NULL
proportions	NULL
of	NULL
double	NULL
positive	NULL
(	NULL
DP	NULL
)	NULL
cells	NULL
which	NULL
developed	NULL
from	NULL
the	NULL
Id3-transduced	NULL
CD1atCD34+*	NULL
thymocytes	NULL
were	NULL
dramatically	NULL
lower	NULL
than	NULL
observed	NULL
for	NULL
untransduced	NULL
cells	NULL
(	NULL
Figure	NULL
2	NULL
;	NULL
3	NULL
versus	NULL
88	NULL
%	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
significant	NULL
fewer	NULL
TCRafB*	NULL
T	NULL
cells	NULL
were	NULL
present	NULL
in	NULL
the	NULL
Id3-transduced	NULL
cell	NULL
sample	NULL
(	NULL
3	NULL
versus	NULL
64	NULL
%	NULL
)	NULL
.	NULL

However	NULL
,	NULL
similar	NULL
percentages	NULL
of	NULL
TCRYy8*	NULL
T	NULL
cells	NULL
were	NULL
recovered	NULL
from	NULL
the	NULL
transduced	NULL
and	NULL
untransduced	NULL
populations	NULL
(	NULL
1.1	NULL
versus	NULL
0.7	NULL
%	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
ratio	NULL
TCRoRB	NULL
to	NULL
TCRYy8	NULL
was	NULL
dramatically	NULL
affected	NULL
by	NULL
Id3	NULL
overexpression	NULL
(	NULL
3	NULL
versus	NULL
90	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
Id3~	NULL
GFP*+*CD1atCD34+*	NULL
cells	NULL
had	NULL
lost	NULL
CD1a	NULL
after	NULL
FTOC	NULL
,	NULL
although	NULL
all	NULL
cells	NULL
expressed	NULL
CD5	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
virtually	NULL
all	NULL
untransduced	NULL
cells	NULL
remained	NULL
positive	NULL
for	NULL
CD1a	NULL
and	NULL
CDS	NULL
.	NULL

Though	NULL
control-transduced	NULL
CD1atCD34+*	NULL
thymocytes	NULL
were	NULL
unable	NULL
to	NULL
develop	NULL
into	NULL
NK	NULL
cells	NULL
,	NULL
CD3-~CD56*	NULL
NK	NULL
cells	NULL
did	NULL
develop	NULL
from	NULL
the	NULL
Id3-transduced	NULL
cells	NULL
(	NULL
7.6	NULL
%	NULL
of	NULL
the	NULL
Id3-transduced	NULL
cells	NULL
versus	NULL
0	NULL
%	NULL
of	NULL
the	NULL
untransduced	NULL
cells	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
Id3	NULL
overexpression	NULL
in	NULL
CD1atCD34*	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
strong	NULL
Control	NULL
of	NULL
T	NULL
cell	NULL
development	NULL
by	NULL
bHLH	NULL
proteins	NULL
Id3-IRES-GFP	NULL
nontransduced	NULL
TCRaf-PE	NULL
TCRyS-TRC	NULL
TCRyS-TRC	NULL
FSC	NULL
4	NULL
%	NULL
nontransduced	NULL
Id3-IRES-GFP	NULL
88	NULL
3.5	NULL
3	NULL
wy	NULL
.	NULL

E	NULL
;	NULL
1	NULL
2.	NULL
a	NULL
}	NULL
5	NULL
}	NULL
(	NULL
8	NULL
0	NULL
%	NULL
.	NULL

c	NULL
orrm	NULL
I0	NULL
2	NULL
-	NULL
I5.5	NULL
CD8-TRC	NULL
CD8-TRC	NULL
0.2	NULL
0.6	NULL
mid	NULL
w	NULL
4	NULL
:	NULL
a.	NULL
a	NULL
.	NULL

5	NULL
:	NULL
64	NULL
ed	NULL
19	NULL
Fy	NULL
a	NULL
A	NULL
J-Ok	NULL
;	NULL
O	NULL
Byp	NULL
.	NULL

ll	NULL
s	NULL
CbS-TIRC	NULL
'	NULL
CD3-TRC	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Three-color	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
cells	NULL
recovered	NULL
from	NULL
an	NULL
FTOC	NULL
seeded	NULL
with	NULL
Id3-transduced	NULL
CD1a*CD34*	NULL
thymocytes	NULL
.	NULL

Sorted	NULL
CD1a*CD34*	NULL
thymocytes	NULL
(	NULL
>	NULL
99	NULL
%	NULL
pure	NULL
upon	NULL
reanalysis	NULL
)	NULL
were	NULL
transduced	NULL
with	NULL
the	NULL
retrovirus	NULL
containing	NULL
the	NULL
Id3-IRES-GFP	NULL
construct	NULL
and	NULL
cultured	NULL
in	NULL
an	NULL
FTOC	NULL
for	NULL
3	NULL
weeks	NULL
.	NULL

Single	NULL
cell	NULL
suspensions	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
indicated	NULL
surface	NULL
antibodies	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
surface	NULL
antigens	NULL
is	NULL
shown	NULL
after	NULL
electronic	NULL
gating	NULL
on	NULL
GFP	NULL
or	NULL
GFP-	NULL
cells	NULL
.	NULL

Numbers	NULL
in	NULL
the	NULL
dot	NULL
plots	NULL
represent	NULL
percentages	NULL
of	NULL
dots	NULL
in	NULL
each	NULL
quadrant	NULL
.	NULL

inhibition	NULL
of	NULL
B	NULL
but	NULL
not	NULL
of	NULL
y5	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Moreover	NULL
,	NULL
incubation	NULL
of	NULL
Id3-transduced	NULL
cells	NULL
in	NULL
an	NULL
FTOC	NULL
resulted	NULL
in	NULL
downregulation	NULL
of	NULL
CD1a	NULL
and	NULL
led	NULL
to	NULL
development	NULL
of	NULL
CD56	NULL
*	NULL
cells	NULL
.	NULL

Overexpression	NULL
of	NULL
Id3	NULL
in	NULL
CD4	NULL
ISP	NULL
thymocytes	NULL
blocks	NULL
development	NULL
of	NULL
TCRafBÂ®	NULL
but	NULL
not	NULL
T	NULL
cells	NULL
in	NULL
an	NULL
FTOC	NULL
The	NULL
results	NULL
presented	NULL
in	NULL
Figure	NULL
2	NULL
indicate	NULL
that	NULL
development	NULL
from	NULL
CD1latCD34Â¢*	NULL
cells	NULL
is	NULL
strongly	NULL
inhibited	NULL
while	NULL
development	NULL
of	NULL
TCRY6	NULL
cells	NULL
is	NULL
much	NULL
less	NULL
affected	NULL
.	NULL

The	NULL
stage	NULL
that	NULL
follows	NULL
the	NULL
CD1atCD34*	NULL
stage	NULL
expresses	NULL
CD4	NULL
but	NULL
lacks	NULL
CD8	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Ramiro	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
have	NULL
documented	NULL
that	NULL
TCRP	NULL
gene	NULL
rearrangements	NULL
are	NULL
present	NULL
in	NULL
the	NULL
CD4	NULL
ISP	NULL
.	NULL

Southern	NULL
blot	NULL
analysis	NULL
of	NULL
TCRB	NULL
rearrangements	NULL
in	NULL
CD34	NULL
*	NULL
and	NULL
CD4	NULL
ISP	NULL
populations	NULL
using	NULL
JB1-	NULL
and	NULL
JB2-specific	NULL
probes	NULL
have	NULL
confirmed	NULL
the	NULL
data	NULL
of	NULL
Ramiro	NULL
and	NULL
collaborators	NULL
,	NULL
but	NULL
also	NULL
indicated	NULL
that	NULL
85	NULL
%	NULL
of	NULL
the	NULL
TCRB	NULL
alleles	NULL
are	NULL
still	NULL
in	NULL
the	NULL
germline	NULL
configuration	NULL
(	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

We	NULL
have	NULL
found	NULL
,	NULL
moreover	NULL
,	NULL
that	NULL
almost	NULL
all	NULL
(	NULL
>	NULL
95	NULL
%	NULL
)	NULL
CD4	NULL
ISP	NULL
cells	NULL
have	NULL
rearranged	NULL
TCR	NULL
loci	NULL
and	NULL
that	NULL
35	NULL
%	NULL
of	NULL
the	NULL
alleles	NULL
have	NULL
TCRy	NULL
rearrangements	NULL
(	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
all	NULL
CD4	NULL
ISP	NULL
cells	NULL
have	NULL
one	NULL
or	NULL
more	NULL
TCR	NULL
genes	NULL
in	NULL
rearranged	NULL
form	NULL
,	NULL
they	NULL
are	NULL
completely	NULL
unable	NULL
to	NULL
develop	NULL
into	NULL
NK	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
they	NULL
are	NULL
fully	NULL
committed	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
Id3	NULL
influences	NULL
T	NULL
cell	NULL
development	NULL
after	NULL
complete	NULL
commitment	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
,	NULL
CD4	NULL
ISP	NULL
cells	NULL
were	NULL
sorted	NULL
from	NULL
CD	NULL
#	NULL
8-depleted	NULL
thymocytes	NULL
,	NULL
transduced	NULL
with	NULL
viruses	NULL
harboring	NULL
either	NULL
the	NULL
control	NULL
IRES-GFP	NULL
or	NULL
Id3-IRES-GFP	NULL
DNAs	NULL
and	NULL
cultured	NULL
for	NULL
12	NULL
days	NULL
in	NULL
an	NULL
FTOC	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
one	NULL
of	NULL
four	NULL
representative	NULL
experiments	NULL
shown	NULL
in	NULL
Figure	NULL
3	NULL
revealed	NULL
that	NULL
12	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
recovered	NULL
from	NULL
the	NULL
FTOC	NULL
were	NULL
GFPÂ¢*	NULL
,	NULL
while	NULL
5	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
Id3-~GFPÂ¢*	NULL
.	NULL

The	NULL
control	NULL
GFP-transduced	NULL
CD4	NULL
ISP	NULL
thymocytes	NULL
developed	NULL
into	NULL
CD1atCDS5*	NULL
cells	NULL
,	NULL
of	NULL
which	NULL
the	NULL
majority	NULL
were	NULL
CD4TCD8*	NULL
DP	NULL
thymocytes	NULL
(	NULL
>	NULL
80	NULL
%	NULL
)	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Both	NULL
Â«	NULL
B*	NULL
T	NULL
cells	NULL
(	NULL
27	NULL
%	NULL
)	NULL
and	NULL
y5Â¢*	NULL
T	NULL
cells	NULL
were	NULL
present	NULL
(	NULL
0.7	NULL
%	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
no	NULL
CD56*	NULL
NK	NULL
cells	NULL
were	NULL
generated	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
Id3-GFP-transduced	NULL
CD4	NULL
ISP	NULL
thymocytes	NULL
after	NULL
FTOC	NULL
were	NULL
strikingly	NULL
different	NULL
.	NULL

Less	NULL
than	NULL
3	NULL
%	NULL
of	NULL
these	NULL
cells	NULL
expressed	NULL
a	NULL
TCRB	NULL
,	NULL
while	NULL
2	NULL
%	NULL
expressed	NULL
a	NULL
TCRYy8	NULL
.	NULL

In	NULL
terms	NULL
of	NULL
percentages	NULL
,	NULL
there	NULL
was	NULL
even	NULL
an	NULL
increase	NULL
of	NULL
TCRYy8	NULL
cells	NULL
in	NULL
the	NULL
Id3-transduced	NULL
samples	NULL
.	NULL

However	NULL
,	NULL
as	NULL
shown	NULL
below	NULL
,	NULL
the	NULL
absolute	NULL
numbers	NULL
of	NULL
TCRy8	NULL
cells	NULL
in	NULL
both	NULL
samples	NULL
are	NULL
not	NULL
significantly	NULL
different	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
Id3	NULL
overexpression	NULL
strongly	NULL
inhibited	NULL
differentiation	NULL
of	NULL
CD4	NULL
ISP	NULL
cells	NULL
into	NULL
TCRafB	NULL
cells	NULL
,	NULL
development	NULL
of	NULL
these	NULL
cells	NULL
into	NULL
TCRYy8	NULL
cells	NULL
was	NULL
not	NULL
blocked	NULL
.	NULL

Another	NULL
dramatic	NULL
effect	NULL
was	NULL
the	NULL
development	NULL
of	NULL
relatively	NULL
large	NULL
numbers	NULL
of	NULL
CD1a~	NULL
CD3-CD4-CD5*CD8~-	NULL
cells	NULL
from	NULL
Id3-transduced	NULL
CD4	NULL
ISP	NULL
cells	NULL
as	NULL
60	NULL
%	NULL
of	NULL
these	NULL
cells	NULL
lacked	NULL
expression	NULL
of	NULL
CD1a	NULL
,	NULL
although	NULL
all	NULL
cells	NULL
expressed	NULL
CD5	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
76	NULL
%	NULL
of	NULL
the	NULL
Id3-transduced	NULL
cells	NULL
lacked	NULL
CD4	NULL
and	NULL
CD8	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
some	NULL
cells	NULL
(	NULL
2	NULL
%	NULL
)	NULL
were	NULL
observed	NULL
that	NULL
express	NULL
CD56	NULL
and	NULL
not	NULL
CD3	NULL
may	NULL
suggest	NULL
that	NULL
Id3	NULL
overexpression	NULL
in	NULL
CD4	NULL
ISP	NULL
permits	NULL
some	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
enter	NULL
the	NULL
NK	NULL
cell	NULL
lineage	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
Id3	NULL
overexpression	NULL
on	NULL
TCRy5	NULL
development	NULL
depends	NULL
on	NULL
the	NULL
developmental	NULL
stage	NULL
of	NULL
the	NULL
transduced	NULL
progenitor	NULL
cells	NULL
The	NULL
results	NULL
shown	NULL
in	NULL
Figures	NULL
2	NULL
and	NULL
3	NULL
contrast	NULL
with	NULL
those	NULL
in	NULL
our	NULL
previous	NULL
study	NULL
which	NULL
demonstrated	NULL
that	NULL
Id	NULL
overexpression	NULL
in	NULL
uncommitted	NULL
CD34~*	NULL
progenitor	NULL
cells	NULL
inhibited	NULL
their	NULL
development	NULL
into	NULL
both	NULL
TCRB	NULL
and	NULL
yd	NULL
T	NULL
cells	NULL
in	NULL
an	NULL
FTOC	NULL
.	NULL

This	NULL
is	NULL
illustrated	NULL
more	NULL
clearly	NULL
in	NULL
Table	NULL
I	NULL
which	NULL
summarizes	NULL
the	NULL
results	NULL
of	NULL
eight	NULL
experiments	NULL
;	NULL
two	NULL
with	NULL
CD34+	NULL
fetal	NULL
liver	NULL
cells	NULL
,	NULL
three	NULL
with	NULL
CD1aCD34*	NULL
thymic	NULL
precursors	NULL
and	NULL
three	NULL
with	NULL
committed	NULL
CD4	NULL
ISP	NULL
cells	NULL
.	NULL

Table	NULL
I	NULL
shows	NULL
that	NULL
the	NULL
proportions	NULL
of	NULL
IRES-GFP*	NULL
and	NULL
Id3-IRES-GFP+*	NULL
cells	NULL
before	NULL
the	NULL
FTOC	NULL
are	NULL
similar	NULL
.	NULL

2795	NULL
B.Blom	NULL
et	NULL
al	NULL
.	NULL

&	NULL
&	NULL
fo	NULL
}	NULL
oj	NULL
&	NULL
S	NULL
IRES-GFP	NULL
L	NULL
A	NULL
.	NULL

<	NULL
o	NULL
0	NULL
al	NULL
n	NULL
Â«	NULL
a	NULL
ch	NULL
.	NULL

3	NULL
o	NULL
6	NULL
E	NULL
;	NULL
0.7	NULL
Â£	NULL
TCRyS-TRC	NULL
w	NULL
4	NULL
Ae	NULL
:	NULL
&	NULL
j	NULL
&	NULL
o	NULL
|	NULL
o	NULL
o	NULL
o	NULL
CDSs-TRC	NULL
CD5-TRC	NULL
0.3	NULL
0.3	NULL
0.5	NULL
l	NULL
Lu	NULL
Q	NULL
.	NULL

A	NULL
.	NULL

Â«	NULL
&	NULL
w	NULL
&	NULL
fols_	NULL
_-	NULL
Â§	NULL
0	NULL
fey	NULL
~	NULL
.	NULL

.	NULL

35	NULL
0	NULL
:	NULL
l	NULL
CD3-TRC	NULL
CD3-TRC	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Three-color	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
IRES-GFP-	NULL
and	NULL
Id3-IRES-GFP-transduced	NULL
CD4	NULL
ISP	NULL
thymocytes	NULL
cultured	NULL
in	NULL
an	NULL
FTOC	NULL
.	NULL

CD4	NULL
ISP	NULL
thymocytes	NULL
were	NULL
sorted	NULL
(	NULL
>	NULL
99	NULL
%	NULL
pure	NULL
upon	NULL
reanalysis	NULL
)	NULL
and	NULL
transduced	NULL
with	NULL
the	NULL
retrovirus	NULL
containing	NULL
the	NULL
control	NULL
IRES-GFP	NULL
or	NULL
the	NULL
retrovirus	NULL
expressing	NULL
Id3-IRES-GFP	NULL
and	NULL
cultured	NULL
in	NULL
FTOC	NULL
for	NULL
12	NULL
days	NULL
.	NULL

Single	NULL
cell	NULL
suspensions	NULL
were	NULL
prepared	NULL
and	NULL
stained	NULL
with	NULL
PE-and	NULL
TRC-conjugated	NULL
antibodies	NULL
against	NULL
different	NULL
surface	NULL
antigens	NULL
.	NULL

Flow	NULL
cytometry	NULL
was	NULL
performed	NULL
and	NULL
cells	NULL
were	NULL
analyzed	NULL
for	NULL
the	NULL
indicated	NULL
surface	NULL
markers	NULL
after	NULL
gating	NULL
on	NULL
the	NULL
control	NULL
GFP*	NULL
cells	NULL
or	NULL
the	NULL
1Id3-IRES-GFP*	NULL
cells	NULL
.	NULL

Numbers	NULL
in	NULL
the	NULL
dot	NULL
plots	NULL
represent	NULL
percentages	NULL
of	NULL
dots	NULL
in	NULL
each	NULL
quadrant	NULL
.	NULL

Thus	NULL
the	NULL
input	NULL
numbers	NULL
of	NULL
Id3-	NULL
and	NULL
control-transduced	NULL
progenitor	NULL
cells	NULL
were	NULL
comparable	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
percentages	NULL
of	NULL
GFP	NULL
*	NULL
cells	NULL
in	NULL
Id3-transduced	NULL
cells	NULL
after	NULL
the	NULL
FTOC	NULL
were	NULL
lower	NULL
than	NULL
that	NULL
in	NULL
the	NULL
control-transduced	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
most	NULL
likely	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
proliferation	NULL
induced	NULL
by	NULL
B	NULL
selection	NULL
does	NULL
not	NULL
occur	NULL
in	NULL
the	NULL
Id3-transduced	NULL
cells	NULL
(	NULL
vide	NULL
infra	NULL
)	NULL
.	NULL

To	NULL
allow	NULL
a	NULL
meaningful	NULL
assessment	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
Id3	NULL
on	NULL
T	NULL
cell	NULL
development	NULL
,	NULL
we	NULL
therefore	NULL
calculated	NULL
the	NULL
absolute	NULL
number	NULL
of	NULL
GFP*TCR	NULL
Â«	NULL
fB	NULL
and	NULL
GFP*TCRyS*	NULL
cells	NULL
harvested	NULL
from	NULL
each	NULL
experiment	NULL
.	NULL

Since	NULL
the	NULL
same	NULL
number	NULL
of	NULL
lobes	NULL
could	NULL
not	NULL
always	NULL
be	NULL
harvested	NULL
,	NULL
and	NULL
therefore	NULL
the	NULL
total	NULL
cell	NULL
recoveries	NULL
of	NULL
each	NULL
sample	NULL
were	NULL
different	NULL
,	NULL
we	NULL
expressed	NULL
the	NULL
number	NULL
as	NULL
the	NULL
amount	NULL
of	NULL
GFP+	NULL
cells	NULL
per	NULL
108	NULL
total	NULL
(	NULL
GFP+	NULL
and	NULL
GFP-	NULL
)	NULL
cells	NULL
.	NULL

Control	NULL
GFP-transduced	NULL
cells	NULL
were	NULL
not	NULL
included	NULL
in	NULL
two	NULL
experiments	NULL
(	NULL
experiment	NULL
3	NULL
with	NULL
CD1a-CD34*	NULL
thymocytes	NULL
and	NULL
experiment	NULL
1	NULL
with	NULL
CD4	NULL
ISP	NULL
cells	NULL
)	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
we	NULL
calculated	NULL
the	NULL
number	NULL
of	NULL
untransduced	NULL
TCRaf	NULL
and	NULL
y65	NULL
cells	NULL
that	NULL
developed	NULL
from	NULL
the	NULL
same	NULL
input	NULL
number	NULL
as	NULL
that	NULL
2796	NULL
of	NULL
the	NULL
Id3-transduced	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
Table	NULL
I	NULL
clearly	NULL
indicate	NULL
that	NULL
enforced	NULL
expression	NULL
of	NULL
Id3	NULL
in	NULL
CD34*	NULL
fetal	NULL
liver	NULL
(	NULL
two	NULL
experiments	NULL
)	NULL
and	NULL
CD1a-CD34Â¢	NULL
cells	NULL
(	NULL
three	NULL
experiments	NULL
)	NULL
strongly	NULL
blocked	NULL
development	NULL
of	NULL
both	NULL
TCRaRB	NULL
and	NULL
48	NULL
cells	NULL
.	NULL

Id3	NULL
expression	NULL
also	NULL
inhibited	NULL
TCRaB	NULL
development	NULL
of	NULL
CD4	NULL
ISP	NULL
cells	NULL
in	NULL
all	NULL
three	NULL
experiments	NULL
.	NULL

However	NULL
,	NULL
the	NULL
absolute	NULL
numbers	NULL
of	NULL
TCRY8	NULL
cells	NULL
recovered	NULL
from	NULL
the	NULL
Id3-	NULL
and	NULL
control-transduced	NULL
CD4	NULL
ISP	NULL
cells	NULL
were	NULL
the	NULL
same	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
after	NULL
the	NULL
T/NK	NULL
checkpoint	NULL
,	NULL
bHLH	NULL
factors	NULL
continue	NULL
to	NULL
be	NULL
required	NULL
for	NULL
TCRafB	NULL
but	NULL
not	NULL
for	NULL
TCRY8	NULL
development	NULL
.	NULL

Enforced	NULL
expression	NULL
of	NULL
Id3	NULL
in	NULL
CD1a-CD34*	NULL
cells	NULL
prevents	NULL
the	NULL
appearance	NULL
of	NULL
cells	NULL
with	NULL
TCRS	NULL
rearrangements	NULL
and	NULL
with	NULL
upregulated	NULL
RAG1	NULL
and	NULL
RAGZ2	NULL
mRNA	NULL
and	NULL
downregulates	NULL
pT	NULL
&	NULL
mRNA	NULL
In	NULL
our	NULL
previous	NULL
study	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
enforced	NULL
Id3	NULL
expression	NULL
prevents	NULL
the	NULL
appearance	NULL
of	NULL
TCRRB	NULL
rearrangements	NULL
in	NULL
CD1a	NULL
CD34	NULL
*	NULL
cells	NULL
cultured	NULL
in	NULL
IL-7	NULL
(	NULL
Heemskerk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
Id	NULL
specifically	NULL
affects	NULL
rearrangements	NULL
or	NULL
whether	NULL
Id3	NULL
interferes	NULL
with	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
at	NULL
other	NULL
loci	NULL
as	NULL
well	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
Id3	NULL
on	NULL
TCR8	NULL
V8l-J81	NULL
rearrangements	NULL
in	NULL
CD1a-CD34*	NULL
cells	NULL
cultured	NULL
in	NULL
IL-7	NULL
and	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
)	NULL
using	NULL
a	NULL
PCR	NULL
technique	NULL
.	NULL

CD1a	NULL
CD34*	NULL
cells	NULL
were	NULL
sorted	NULL
,	NULL
transduced	NULL
with	NULL
Id3	NULL
or	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
and	NULL
cultured	NULL
for	NULL
6	NULL
days	NULL
in	NULL
IL-7	NULL
.	NULL

Since	NULL
the	NULL
transduced	NULL
gene	NULL
is	NULL
expressed	NULL
2	NULL
days	NULL
after	NULL
the	NULL
transduction	NULL
procedure	NULL
,	NULL
Id3	NULL
is	NULL
expressed	NULL
for	NULL
the	NULL
last	NULL
4	NULL
days	NULL
of	NULL
the	NULL
culture	NULL
period	NULL
.	NULL

The	NULL
GFP+	NULL
cells	NULL
were	NULL
sorted	NULL
from	NULL
both	NULL
cultures	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
was	NULL
isolated	NULL
and	NULL
subjected	NULL
to	NULL
a	NULL
PCR	NULL
.	NULL

Figure	NULL
4	NULL
shows	NULL
a	NULL
band	NULL
with	NULL
a	NULL
very	NULL
low	NULL
intensity	NULL
following	NULL
Southern	NULL
blot	NULL
of	NULL
the	NULL
PCR	NULL
product	NULL
from	NULL
DNA	NULL
of	NULL
freshly	NULL
isolated	NULL
CD1a~	NULL
CD34*	NULL
cells	NULL
.	NULL

This	NULL
may	NULL
either	NULL
reflect	NULL
a	NULL
low	NULL
level	NULL
of	NULL
V8l-J81	NULL
rearrangements	NULL
in	NULL
this	NULL
population	NULL
or	NULL
be	NULL
due	NULL
to	NULL
a	NULL
few	NULL
contaminating	NULL
CD1a*CD34*	NULL
cells	NULL
in	NULL
the	NULL
cell	NULL
preparation	NULL
.	NULL

The	NULL
number	NULL
of	NULL
the	NULL
V8l-J81	NULL
rearrangements	NULL
strongly	NULL
increased	NULL
when	NULL
control-transduced	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
IL-7	NULL
and	NULL
SCF	NULL
(	NULL
Figure	NULL
4	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
was	NULL
of	NULL
the	NULL
same	NULL
level	NULL
as	NULL
those	NULL
detected	NULL
in	NULL
CD1atCD34*	NULL
cells	NULL
isolated	NULL
in	NULL
the	NULL
same	NULL
sort	NULL
as	NULL
cells	NULL
(	NULL
Figure	NULL
4	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Enforced	NULL
expression	NULL
of	NULL
Id3	NULL
completely	NULL
inhibited	NULL
the	NULL
increase	NULL
of	NULL
V8l-J81	NULL
rearrangements	NULL
by	NULL
IL-7	NULL
and	NULL
SCF	NULL
(	NULL
Figure	NULL
4	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
enforced	NULL
expression	NULL
of	NULL
Id3	NULL
inhibited	NULL
induction	NULL
of	NULL
both	NULL
TCR8	NULL
and	NULL
TCRB	NULL
gene	NULL
rearrangements	NULL
by	NULL
IL-7	NULL
and	NULL
SCF	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
effect	NULL
of	NULL
Id3	NULL
on	NULL
expression	NULL
of	NULL
RAG1	NULL
and	NULL
RAG2	NULL
.	NULL

CD1aCD34	NULL
*	NULL
and	NULL
CD1a*tCD34*	NULL
cells	NULL
were	NULL
sorted	NULL
,	NULL
transduced	NULL
with	NULL
Id3	NULL
or	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
and	NULL
cultured	NULL
for	NULL
6	NULL
days	NULL
in	NULL
IL-7	NULL
.	NULL

The	NULL
GFP*	NULL
cells	NULL
were	NULL
sorted	NULL
from	NULL
both	NULL
cultures	NULL
,	NULL
and	NULL
the	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
reverse	NULL
transcribed	NULL
.	NULL

The	NULL
cDNA	NULL
samples	NULL
were	NULL
subjected	NULL
to	NULL
PCR	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
HPRT	NULL
,	NULL
RAG1	NULL
and	NULL
RAG2	NULL
.	NULL

Figure	NULL
5	NULL
shows	NULL
that	NULL
cells	NULL
overexpressing	NULL
Id3	NULL
in	NULL
both	NULL
CD1a-CD34*	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
;	NULL
the	NULL
two	NULL
lanes	NULL
show	NULL
the	NULL
bands	NULL
of	NULL
undiluted	NULL
and	NULL
one-fofth	NULL
diluted	NULL
samples	NULL
,	NULL
respectively	NULL
)	NULL
and	NULL
CD1lat	NULL
CD34*	NULL
(	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
)	NULL
have	NULL
reduced	NULL
levels	NULL
of	NULL
RAG1	NULL
and	NULL
RAG2	NULL
compared	NULL
with	NULL
the	NULL
control	NULL
vector-transduced	NULL
CD1aCD34+*	NULL
cells	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
and	NULL
CD1atCD34+*	NULL
cells	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

In	NULL
the	NULL
same	NULL
experiment	NULL
,	NULL
we	NULL
also	NULL
analyzed	NULL
pT	NULL
mRNA	NULL
levels	NULL
,	NULL
because	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
pT	NULL
'	NULL
a	NULL
,	NULL
a	NULL
component	NULL
of	NULL
the	NULL
pre-TCR	NULL
,	NULL
is	NULL
Control	NULL
of	NULL
T	NULL
cell	NULL
development	NULL
by	NULL
bHLH	NULL
proteins	NULL
Table	NULL
I	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
Id3	NULL
overexpression	NULL
on	NULL
the	NULL
numbers	NULL
of	NULL
TCR	NULL
@	NULL
B	NULL
and	NULL
48	NULL
cells	NULL
that	NULL
developed	NULL
from	NULL
uncommitted	NULL
and	NULL
committed	NULL
T	NULL
cell	NULL
progenitors	NULL
Cell	NULL
population	NULL
Exp	NULL
.	NULL

%	NULL
Transduced	NULL
cells	NULL
No	NULL
.	NULL

of	NULL
GFP+	NULL
cells	NULL
with	NULL
TCRa	NULL
&	NULL
B	NULL
or	NULL
y8	NULL
per	NULL
10Â°	NULL
cells	NULL
1d3-IRES-GFP	NULL
IRES-GFP	NULL
1d3	NULL
Control	NULL
Before*	NULL
AfterÂ®	NULL
Before*	NULL
AfterÂ®	NULL
B	NULL
y6	NULL
B	NULL
y6	NULL
CD34	NULL
*	NULL
1	NULL
52	NULL
13	NULL
49	NULL
23	NULL
)	NULL
0	NULL
23	NULL
000	NULL
16	NULL
100	NULL
fetal	NULL
liver	NULL
2	NULL
35	NULL
2	NULL
31	NULL
18	NULL
0	NULL
200	NULL
12	NULL
600	NULL
18	NULL
000	NULL
CD1a	NULL
CD34*	NULL
3	NULL
12	NULL
2	NULL
10	NULL
6	NULL
180	NULL
600	NULL
10	NULL
200	NULL
4800	NULL
thymus	NULL
4	NULL
10	NULL
1	NULL
14	NULL
14	NULL
200	NULL
0	NULL
37	NULL
800	NULL
2800	NULL
5	NULL
36	NULL
2.6	NULL
ND	NULL
780	NULL
360	NULL
108	NULL
000	NULL
8640	NULL
CD1iatCD4*CD-	NULL
d	NULL
8	NULL
3	NULL
ND	NULL
900	NULL
1200	NULL
24	NULL
000	NULL
800	NULL
thymus	NULL
7	NULL
3	NULL
1	NULL
4	NULL
4	NULL
700	NULL
240	NULL
17	NULL
600	NULL
240	NULL
8	NULL
13	NULL
5	NULL
13	NULL
12	NULL
1500	NULL
1000	NULL
32	NULL
400	NULL
840	NULL
After	NULL
each	NULL
FTOC	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
total	NULL
number	NULL
of	NULL
recovered	NULL
cells	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
GFP	NULL
cells	NULL
and	NULL
the	NULL
phenotype	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
data	NULL
,	NULL
we	NULL
calculated	NULL
the	NULL
total	NULL
numbers	NULL
of	NULL
GFP*	NULL
f	NULL
and	NULL
y8	NULL
cells	NULL
.	NULL

To	NULL
allow	NULL
for	NULL
a	NULL
comparison	NULL
of	NULL
all	NULL
experiments	NULL
,	NULL
we	NULL
expressed	NULL
the	NULL
numbers	NULL
of	NULL
recovered	NULL
af	NULL
}	NULL
and	NULL
18	NULL
cells	NULL
per	NULL
10Â°	NULL
total	NULL
(	NULL
GFP+	NULL
and	NULL
GFP	NULL
)	NULL
cells	NULL
.	NULL

In	NULL
experiments	NULL
5	NULL
and	NULL
6	NULL
,	NULL
we	NULL
calculated	NULL
the	NULL
numbers	NULL
of	NULL
untransduced	NULL
cells	NULL
that	NULL
developed	NULL
from	NULL
the	NULL
same	NULL
input	NULL
number	NULL
as	NULL
Id3-transduced	NULL
cells	NULL
.	NULL

**Before	NULL
'	NULL
and	NULL
'after	NULL
'	NULL
refer	NULL
to	NULL
the	NULL
percentage	NULL
of	NULL
GFP*	NULL
cells	NULL
before	NULL
and	NULL
after	NULL
incubation	NULL
of	NULL
the	NULL
transduced	NULL
cells	NULL
in	NULL
the	NULL
FTOC	NULL
.	NULL

crucial	NULL
for	NULL
optimal	NULL
development	NULL
of	NULL
TCRafB	NULL
cells	NULL
,	NULL
but	NULL
is	NULL
not	NULL
required	NULL
for	NULL
development	NULL
of	NULL
TCRYy8*	NULL
cells	NULL
(	NULL
Fehling	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

It	NULL
is	NULL
demonstrated	NULL
in	NULL
Figure	NULL
5	NULL
that	NULL
pTo	NULL
is	NULL
strongly	NULL
downregulated	NULL
by	NULL
enforced	NULL
expression	NULL
of	NULL
Id3	NULL
,	NULL
both	NULL
in	NULL
CD1a-CD34*	NULL
(	NULL
third	NULL
panel	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
and	NULL
in	NULL
CD1a*CD34*	NULL
cells	NULL
(	NULL
third	NULL
panel	NULL
,	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
)	NULL
as	NULL
the	NULL
intensities	NULL
of	NULL
the	NULL
pTG	NULL
bands	NULL
in	NULL
the	NULL
Id3-transduced	NULL
cells	NULL
are	NULL
even	NULL
lower	NULL
than	NULL
in	NULL
the	NULL
freshly	NULL
isolated	NULL
CD1a~	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
CD1atCD34*	NULL
cells	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
determined	NULL
the	NULL
intensities	NULL
of	NULL
the	NULL
PCR	NULL
bands	NULL
using	NULL
video	NULL
densitometry	NULL
employing	NULL
the	NULL
Eagle	NULL
Eye	NULL
still	NULL
video	NULL
system	NULL
and	NULL
Eagle	NULL
Sight	NULL
software	NULL
.	NULL

From	NULL
the	NULL
measured	NULL
intensities	NULL
,	NULL
we	NULL
calculated	NULL
the	NULL
ratios	NULL
RAG1	NULL
:	NULL
HPRT	NULL
,	NULL
RAG2	NULL
:	NULL
HPRT	NULL
and	NULL
pTo	NULL
:	NULL
HPRT	NULL
.	NULL

The	NULL
calculated	NULL
RAG1	NULL
:	NULL
HPRT	NULL
ratio	NULL
for	NULL
freshly	NULL
isolated	NULL
CD1aCD34Â¢*	NULL
was	NULL
0.04	NULL
;	NULL
following	NULL
incubation	NULL
of	NULL
the	NULL
control	NULL
,	NULL
the	NULL
ratio	NULL
increased	NULL
to	NULL
1.33	NULL
,	NULL
while	NULL
the	NULL
ratio	NULL
in	NULL
the	NULL
Id3-transduced	NULL
sample	NULL
was	NULL
0.07	NULL
.	NULL

For	NULL
the	NULL
CD1a*CD34*	NULL
samples	NULL
,	NULL
the	NULL
RAG1	NULL
:	NULL
HPRT	NULL
ratios	NULL
were	NULL
0.76	NULL
,	NULL
2.1	NULL
and	NULL
0.5	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
similar	NULL
pattern	NULL
was	NULL
observed	NULL
for	NULL
RAG2	NULL
.	NULL

Although	NULL
these	NULL
measurements	NULL
should	NULL
be	NULL
interpreted	NULL
with	NULL
caution	NULL
,	NULL
they	NULL
suggest	NULL
that	NULL
overexpression	NULL
of	NULL
Id3	NULL
prevented	NULL
upregulation	NULL
of	NULL
Id3	NULL
rather	NULL
than	NULL
downregulated	NULL
expression	NULL
of	NULL
RAG1	NULL
and	NULL
RAG2	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
pT	NULL
'	NULL
a	NULL
:	NULL
HPRT	NULL
ratios	NULL
was	NULL
different	NULL
.	NULL

The	NULL
ratio	NULL
in	NULL
the	NULL
freshly	NULL
isolated	NULL
CD1a~	NULL
CD34*	NULL
cells	NULL
was	NULL
0.8	NULL
;	NULL
following	NULL
culture	NULL
,	NULL
the	NULL
control	NULL
gave	NULL
a	NULL
ratio	NULL
of	NULL
1.0	NULL
while	NULL
in	NULL
the	NULL
Id3-transduced	NULL
sample	NULL
the	NULL
pTo	NULL
:	NULL
HPRT	NULL
ratio	NULL
was	NULL
0.03	NULL
.	NULL

The	NULL
pTo	NULL
:	NULL
HPRT	NULL
ratios	NULL
determined	NULL
in	NULL
the	NULL
CD1a+CD34	NULL
*	NULL
samples	NULL
were	NULL
1.4	NULL
,	NULL
1.9	NULL
and	NULL
0.02	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
Id3	NULL
overexpression	NULL
results	NULL
in	NULL
downregulation	NULL
of	NULL
pT	NULL
'	NULL
G	NULL
mRNA	NULL
.	NULL

CD1a	NULL
CD4	NULL
CD3	NULL
cells	NULL
recovered	NULL
from	NULL
Id3-IRES-GFP*	NULL
CD4	NULL
ISP	NULL
thymocytes	NULL
cultured	NULL
in	NULL
FTOC	NULL
can	NULL
be	NULL
expanded	NULL
with	NULL
IL-2	NULL
and	NULL
show	NULL
characteristics	NULL
of	NULL
both	NULL
pre-T	NULL
cells	NULL
and	NULL
NK	NULL
cells	NULL
The	NULL
CD1a-CD3-CD4~	NULL
cells	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
recovered	NULL
from	NULL
the	NULL
FTOC	NULL
seeded	NULL
with	NULL
Id3-IRES-GFP-transduced	NULL
CD4	NULL
ISP	NULL
cells	NULL
also	NULL
expressed	NULL
CD2	NULL
and	NULL
CD7	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
recovery	NULL
of	NULL
these	NULL
cells	NULL
was	NULL
unexpected	NULL
as	NULL
no	NULL
CD3~	NULL
CD4~	NULL
cells	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
FTOC	NULL
with	NULL
untransduced	NULL
or	NULL
control-transduced	NULL
CD4	NULL
ISP	NULL
cells	NULL
.	NULL

These	NULL
CD1a~	NULL
TCR	NULL
Vol-Jol	NULL
DNA	NULL
control	NULL
L	NULL
1	NULL
%	NULL
3	NULL
4	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

TCRV81-J81	NULL
rearrangements	NULL
in	NULL
freshly	NULL
isolated	NULL
CD1a	NULL
CD34	NULL
*	NULL
and	NULL
CD1a*CD34*	NULL
cells	NULL
and	NULL
Id3~	NULL
and	NULL
control-transduced	NULL
CD1a~	NULL
CD34	NULL
*cells	NULL
,	NULL
cultured	NULL
in	NULL
IL-7	NULL
and	NULL
SCF	NULL
.	NULL

CD1a	NULL
CD34*	NULL
and	NULL
CD1a*CD34	NULL
*cells	NULL
were	NULL
isolated	NULL
and	NULL
the	NULL
CD1a	NULL
CD34	NULL
*	NULL
cells	NULL
were	NULL
transduced	NULL
with	NULL
GFP	NULL
or	NULL
with	NULL
Id3-GFP	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

The	NULL
transduced	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
a	NULL
combination	NULL
of	NULL
IL-7	NULL
and	NULL
SCF	NULL
for	NULL
6	NULL
days	NULL
.	NULL

After	NULL
this	NULL
culture	NULL
period	NULL
,	NULL
GFP*	NULL
cells	NULL
were	NULL
sorted	NULL
from	NULL
both	NULL
the	NULL
Id3-	NULL
and	NULL
control-transduced	NULL
samples	NULL
(	NULL
>	NULL
98	NULL
%	NULL
pure	NULL
upon	NULL
reanalysis	NULL
)	NULL
.	NULL

DNA	NULL
was	NULL
prepared	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
V81-J81	NULL
rearrangements	NULL
by	NULL
PCR	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
freshly	NULL
isolated	NULL
CD1a~	NULL
CD34*	NULL
cells	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
cultured	NULL
control	NULL
GFP-transduced	NULL
CD1a	NULL
CD34	NULL
*	NULL
cells	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
cultured	NULL
Id3-transduced	NULL
CD1a	NULL
CD34*	NULL
cells	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
freshly	NULL
isolated	NULL
CD1a	NULL
``	NULL
CD34*	NULL
cells	NULL
.	NULL

Amplification	NULL
of	NULL
the	NULL
RAG2	NULL
gene	NULL
was	NULL
done	NULL
to	NULL
control	NULL
for	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
.	NULL

CD2*CD3-CD4-CD7*	NULL
cells	NULL
are	NULL
reminiscent	NULL
of	NULL
CD3	NULL
pre-NK	NULL
cells	NULL
(	NULL
Sanchez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

As	NULL
pre-NK	NULL
cells	NULL
respond	NULL
to	NULL
stimulation	NULL
with	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
and	NULL
IL-2	NULL
(	NULL
Sanchez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
we	NULL
cultured	NULL
the	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
FTOC	NULL
with	NULL
a	NULL
feeder	NULL
mixture	NULL
of	NULL
irradiated	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
,	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
cell	NULL
line	NULL
JY	NULL
,	NULL
PHA	NULL
and	NULL
IL-2	NULL
.	NULL

The	NULL
cells	NULL
recovered	NULL
from	NULL
an	NULL
FTOC	NULL
seeded	NULL
with	NULL
Id3-IRES-GFP-transduced	NULL
CD4	NULL
ISP	NULL
cells	NULL
were	NULL
expandable	NULL
and	NULL
in	NULL
one	NULL
typical	NULL
experiment	NULL
we	NULL
observed	NULL
that	NULL
66	NULL
%	NULL
of	NULL
the	NULL
Id3-GFP*	NULL
cells	NULL
lacked	NULL
CD3	NULL
;	NULL
the	NULL
majority	NULL
of	NULL
these	NULL
CD3~	NULL
cells	NULL
expressed	NULL
the	NULL
NK	NULL
marker	NULL
CD56	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
TCRYy68	NULL
cells	NULL
were	NULL
present	NULL
in	NULL
these	NULL
cultures	NULL
,	NULL
a	NULL
portion	NULL
of	NULL
which	NULL
expressed	NULL
CD56	NULL
.	NULL

The	NULL
Id3-GFP+*CD56*CD3~	NULL
cells	NULL
were	NULL
sorted	NULL
and	NULL
2797	NULL
B.Blom	NULL
et	NULL
al	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
of	NULL
RAG1	NULL
,	NULL
RAG2	NULL
,	NULL
pTa	NULL
and	NULL
HPRT	NULL
expression	NULL
in	NULL
Id3-	NULL
and	NULL
control-transduced	NULL
CD12	NULL
CD34*	NULL
and	NULL
CD1a*CD34*	NULL
cells	NULL
,	NULL
cultured	NULL
in	NULL
IL-7	NULL
and	NULL
SCF	NULL
.	NULL

CD1a	NULL
CD34*	NULL
cells	NULL
were	NULL
isolated	NULL
and	NULL
transduced	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
a	NULL
combination	NULL
of	NULL
IL-7	NULL
and	NULL
SCF	NULL
for	NULL
6	NULL
days	NULL
.	NULL

The	NULL
GFP*	NULL
cells	NULL
were	NULL
sorted	NULL
from	NULL
both	NULL
cultures	NULL
,	NULL
and	NULL
the	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
reverse	NULL
transcribed	NULL
.	NULL

Two	NULL
cDNA	NULL
samples	NULL
,	NULL
one	NULL
undiluted	NULL
(	NULL
first	NULL
lane	NULL
of	NULL
each	NULL
series	NULL
)	NULL
and	NULL
another	NULL
one-fifth	NULL
diluted	NULL
(	NULL
second	NULL
lane	NULL
of	NULL
each	NULL
series	NULL
)	NULL
,	NULL
were	NULL
subjected	NULL
to	NULL
PCR	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
HPRT	NULL
,	NULL
RAG1	NULL
,	NULL
RAG2	NULL
and	NULL
pTa	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
markers	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
freshly	NULL
isolated	NULL
CDia	NULL
CD34*	NULL
cells	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
,	NULL
cultured	NULL
IRES-GFP-transduced	NULL
CD1a	NULL
CD34	NULL
*	NULL
cells	NULL
;	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
,	NULL
cultured	NULL
Id3-IRES-GFP-transduced	NULL
cells	NULL
;	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
,	NULL
freshly	NULL
isolated	NULL
CD1atCD34*	NULL
cells	NULL
;	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
,	NULL
cultured	NULL
IRES-GFP-transduced	NULL
CD1a*CD34*	NULL
cells	NULL
;	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
,	NULL
cultured	NULL
Id3-IRES-GFP-transduced	NULL
CD1a*CD34*	NULL
cells	NULL
;	NULL
lane	NULL
14	NULL
,	NULL
markers	NULL
.	NULL

Lane	NULL
12	NULL
in	NULL
the	NULL
second	NULL
(	NULL
RAG2	NULL
)	NULL
panel	NULL
,	NULL
marked	NULL
by	NULL
an	NULL
arrow	NULL
,	NULL
did	NULL
not	NULL
contain	NULL
material	NULL
,	NULL
but	NULL
since	NULL
the	NULL
one-fifth	NULL
dilution	NULL
(	NULL
lane	NULL
13	NULL
)	NULL
shows	NULL
a	NULL
clear	NULL
signal	NULL
,	NULL
RAG	NULL
expression	NULL
of	NULL
this	NULL
sample	NULL
can	NULL
be	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
lane	NULL
9	NULL
(	NULL
freshly	NULL
isolated	NULL
CD1a*CD34*	NULL
cells	NULL
)	NULL
.	NULL

these	NULL
cells	NULL
were	NULL
shown	NULL
to	NULL
have	NULL
cytotoxic	NULL
activity	NULL
against	NULL
the	NULL
NK-sensitive	NULL
target	NULL
cell	NULL
line	NULL
K562	NULL
,	NULL
but	NULL
not	NULL
against	NULL
an	NULL
NK-resistant	NULL
EBV-B	NULL
cell	NULL
line	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
all	NULL
GFP+*	NULL
cells	NULL
expanded	NULL
from	NULL
the	NULL
FTOC	NULL
with	NULL
control	NULL
GFP-transduced	NULL
CD4*	NULL
ISP	NULL
cells	NULL
were	NULL
TCRy8	NULL
cells	NULL
.	NULL

This	NULL
was	NULL
expected	NULL
because	NULL
TCRY8	NULL
but	NULL
not	NULL
TCRB	NULL
harvested	NULL
from	NULL
the	NULL
FTOC	NULL
can	NULL
be	NULL
cultured	NULL
in	NULL
IL-2	NULL
(	NULL
Res	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
no	NULL
CD3~	NULL
cells	NULL
were	NULL
present	NULL
in	NULL
these	NULL
cultures	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
overexpression	NULL
of	NULL
Id3	NULL
in	NULL
CD4	NULL
ISP	NULL
cells	NULL
selectively	NULL
leads	NULL
to	NULL
development	NULL
of	NULL
CD3~	NULL
cells	NULL
that	NULL
have	NULL
the	NULL
capacity	NULL
to	NULL
respond	NULL
to	NULL
IL-2	NULL
.	NULL

The	NULL
CD3-CD56+*	NULL
cells	NULL
obtained	NULL
from	NULL
Id3-transduced	NULL
CD4	NULL
ISP	NULL
thymic	NULL
precursors	NULL
were	NULL
derived	NULL
from	NULL
cells	NULL
that	NULL
had	NULL
undergone	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
.	NULL

This	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
at	NULL
least	NULL
a	NULL
proportion	NULL
of	NULL
the	NULL
CD1a	NULL
CD3~	NULL
CD4-CD56+*	NULL
cells	NULL
,	NULL
recovered	NULL
from	NULL
the	NULL
FTOC	NULL
and	NULL
expanded	NULL
in	NULL
IL-2-containing	NULL
medium	NULL
,	NULL
had	NULL
rearranged	NULL
TCR	NULL
genes	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
whether	NULL
TCR	NULL
and	NULL
TCRPB	NULL
rearrangements	NULL
were	NULL
present	NULL
in	NULL
Id3-GFP*CDS56*CD3~-cells	NULL
recovered	NULL
from	NULL
an	NULL
FTOC	NULL
seeded	NULL
with	NULL
CD4	NULL
ISP	NULL
Id3-transduced	NULL
thymocytes	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
we	NULL
analyzed	NULL
TCR6S	NULL
and	NULL
TCRB	NULL
rearrangements	NULL
in	NULL
I43-GFP+*CD56Â¢*	NULL
CD3*TCRYyS*	NULL
T	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
same	NULL
FTOCs	NULL
.	NULL

After	NULL
expansion	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
feeders	NULL
,	NULL
they	NULL
were	NULL
sorted	NULL
in	NULL
a	NULL
highly	NULL
stringent	NULL
way	NULL
to	NULL
completely	NULL
remove	NULL
mature	NULL
cells	NULL
(	NULL
>	NULL
99.9	NULL
%	NULL
pure	NULL
)	NULL
and	NULL
TCR	NULL
rearrangements	NULL
were	NULL
analyzed	NULL
by	NULL
PCR	NULL
.	NULL

As	NULL
a	NULL
negative	NULL
control	NULL
,	NULL
DNA	NULL
isolated	NULL
from	NULL
an	NULL
EBV-transformed	NULL
B	NULL
cell	NULL
line	NULL
was	NULL
used	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
Id3-GFP*CD56*CD3*TCRYy8*	NULL
derived	NULL
from	NULL
CD1atCD34*	NULL
and	NULL
CD4	NULL
ISP	NULL
cells	NULL
had	NULL
rearranged	NULL
V81-J81	NULL
and	NULL
DJB	NULL
gene	NULL
2798	NULL
IRES-GFP	NULL
1d3-IRES-GFP	NULL
u	NULL
44	NULL
A	NULL
.	NULL

&	NULL
LO	NULL
[	NULL
=	NULL
)	NULL
o	NULL
56	NULL
NS	NULL
CD3-TRC	NULL
CD3-TRC	NULL
[	NULL
m	NULL
wu	NULL
a	NULL
a.	NULL
ch	NULL
ch	NULL
.	NULL

3	NULL
3	NULL
&	NULL
C	NULL
0	NULL
0	NULL
i-	NULL
g9	NULL
i-TCRyS-TRC	NULL
TCRyS-TRC	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

CD1a	NULL
~CD3~	NULL
cells	NULL
harvested	NULL
from	NULL
an	NULL
FTOC	NULL
seeded	NULL
with	NULL
1d3-IRES-GFP-transduced	NULL
CD4	NULL
ISP	NULL
cells	NULL
can	NULL
be	NULL
expanded	NULL
in	NULL
IL-2-containing	NULL
medium	NULL
.	NULL

Id3-transduced	NULL
CD4	NULL
ISP	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
14	NULL
days	NULL
in	NULL
an	NULL
FTOC	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
the	NULL
GFP-positive	NULL
cells	NULL
were	NULL
sorted	NULL
using	NULL
a	NULL
FACStar	NULL
plus	NULL
and	NULL
stimulated	NULL
with	NULL
a	NULL
feeder	NULL
cell	NULL
mixture	NULL
containing	NULL
PHA	NULL
and	NULL
IL-2	NULL
.	NULL

Following	NULL
14	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
the	NULL
indicated	NULL
PE-	NULL
or	NULL
TRC-conjugated	NULL
antibodies	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
FACScan	NULL
.	NULL

10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
@	NULL
amills	NULL
-|	NULL
ton	NULL
ous	NULL
.	NULL

TCR	NULL
VRBS-	NULL
DJ	NULL
``	NULL
an	NULL
an	NULL
.	NULL

di	NULL
ln	NULL
to	NULL
-	NULL
th	NULL
to	NULL
q	NULL
DNA	NULL
control	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

TCR	NULL
rearrangement	NULL
analysis	NULL
on	NULL
CD3-CD56*	NULL
cells	NULL
obtained	NULL
from	NULL
Id3-IRES-GFP-transduced	NULL
cells	NULL
cultured	NULL
in	NULL
an	NULL
FTOC	NULL
.	NULL

1d3-transduced	NULL
FL	NULL
CD34*	NULL
and	NULL
Id3-transduced	NULL
CD1a	NULL
CD34	NULL
*	NULL
,	NULL
CD1a*CD34*	NULL
and	NULL
CD4	NULL
ISP	NULL
thymocytes	NULL
were	NULL
cultured	NULL
in	NULL
an	NULL
FTOC	NULL
,	NULL
harvested	NULL
and	NULL
expanded	NULL
for	NULL
2	NULL
weeks	NULL
with	NULL
feeders	NULL
.	NULL

Expanded	NULL
cultures	NULL
were	NULL
sorted	NULL
(	NULL
>	NULL
99.9	NULL
%	NULL
pure	NULL
upon	NULL
reanalysis	NULL
)	NULL
for	NULL
Id3-GEP*CD56*CD3~-	NULL
NK	NULL
cells	NULL
and	NULL
I43-GFP*CD56*CD3*	NULL
y8*	NULL
T	NULL
cells	NULL
.	NULL

NK	NULL
cells	NULL
were	NULL
also	NULL
obtained	NULL
from	NULL
cytokine	NULL
(	NULL
IL-2	NULL
,	NULL
IL-7	NULL
and	NULL
SCF	NULL
)	NULL
-induced	NULL
CD34*CD38*	NULL
fetal	NULL
liver	NULL
cells	NULL
and	NULL
CD1a	NULL
CD34*	NULL
thymocytes	NULL
.	NULL

DNA	NULL
was	NULL
isolated	NULL
from	NULL
these	NULL
cells	NULL
and	NULL
analyzed	NULL
by	NULL
PCR	NULL
for	NULL
TCR	NULL
(	NULL
first	NULL
panel	NULL
)	NULL
,	NULL
TCR	NULL
D-JB	NULL
(	NULL
second	NULL
panel	NULL
)	NULL
or	NULL
TCR	NULL
VBS-DJ	NULL
(	NULL
third	NULL
panel	NULL
!	NULL
)	NULL

rearrangements	NULL
using	NULL
the	NULL
primer	NULL
combinations	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

Lanes	NULL
1-10	NULL
contain	NULL
PCR	NULL
products	NULL
amplified	NULL
from	NULL
DNA	NULL
that	NULL
was	NULL
isolated	NULL
from	NULL
total	NULL
thymocytes	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
EBV-B	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
no	NULL
DNA	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
FL	NULL
CD34*CD38*	NULL
plus	NULL
cytokines	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
fetal	NULL
liver	NULL
143	NULL
``	NULL
CDS56*CD3~	NULL
from	NULL
the	NULL
FTOC	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
CD1a	NULL
CD34*	NULL
thymocytes	NULL
plus	NULL
cytokines	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
CD1a*CD34*	NULL
from	NULL
the	NULL
FTOC	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
CD1a*CD34*	NULL
from	NULL
the	NULL
FTOC	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
CD4	NULL
ISP	NULL
from	NULL
the	NULL
FTOC	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
and	NULL
CD4	NULL
ISP	NULL
from	NULL
the	NULL
FTOC	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

segments	NULL
(	NULL
Figure	NULL
7	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
10	NULL
,	NULL
respectively	NULL
)	NULL
while	NULL
an	NULL
EBV-B	NULL
cell	NULL
line	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
did	NULL
not	NULL
reveal	NULL
either	NULL
of	NULL
the	NULL
two	NULL
rearranged	NULL
TCR	NULL
gene	NULL
products	NULL
.	NULL

Surprisingly	NULL
,	NULL
analysis	NULL
of	NULL
DNA	NULL
isolated	NULL
from	NULL
the	NULL
Id3-GFP*CD56*CD3~	NULL
cells	NULL
,	NULL
derived	NULL
from	NULL
FTOC-incubated	NULL
Id3-transduced	NULL
CD1at	NULL
CD34*	NULL
and	NULL
CD4	NULL
ISP	NULL
thymocytes	NULL
,	NULL
both	NULL
revealed	NULL
V8l-J81	NULL
and	NULL
DJB	NULL
rearrangements	NULL
(	NULL
Figure	NULL
7	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
9	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

TCRB	NULL
DJ	NULL
rearrangements	NULL
in	NULL
the	NULL
Id3-GFP*CD56*CD3~	NULL
cells	NULL
derived	NULL
from	NULL
this	NULL
sample	NULL
of	NULL
CD4	NULL
ISP	NULL
thymocytes	NULL
were	NULL
very	NULL
weak	NULL
but	NULL
became	NULL
more	NULL
clearly	NULL
visible	NULL
after	NULL
a	NULL
longer	NULL
exposure	NULL
time	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
completely	NULL
that	NULL
the	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
depicted	NULL
in	NULL
lanes	NULL
7	NULL
and	NULL
9	NULL
are	NULL
derived	NULL
from	NULL
contaminating	NULL
CD3*	NULL
cells	NULL
but	NULL
,	NULL
given	NULL
the	NULL
stringency	NULL
of	NULL
our	NULL
sort	NULL
and	NULL
the	NULL
intensities	NULL
of	NULL
the	NULL
bands	NULL
in	NULL
the	NULL
CD3~	NULL
samples	NULL
compared	NULL
with	NULL
the	NULL
CD3Â¢	NULL
samples	NULL
(	NULL
particularly	NULL
when	NULL
one	NULL
compares	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
,	NULL
we	NULL
feel	NULL
confident	NULL
that	NULL
the	NULL
signals	NULL
are	NULL
not	NULL
derived	NULL
from	NULL
the	NULL
few	NULL
contaminating	NULL
(	NULL
<	NULL
0.1	NULL
%	NULL
)	NULL
CD3	NULL
*	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
although	NULL
no	NULL
TCR	NULL
germline	NULL
bands	NULL
were	NULL
detected	NULL
in	NULL
Southern	NULL
blot	NULL
analysis	NULL
of	NULL
CD4	NULL
ISP	NULL
,	NULL
not	NULL
all	NULL
CD4	NULL
ISP	NULL
cells	NULL
have	NULL
V8l	NULL
to	NULL
J81	NULL
gene	NULL
rearrangements	NULL
(	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
,	NULL
making	NULL
it	NULL
even	NULL
less	NULL
unlikely	NULL
that	NULL
the	NULL
clear	NULL
V81-J81	NULL
rearrangements	NULL
detected	NULL
by	NULL
PCR	NULL
analysis	NULL
of	NULL
the	NULL
Id3*	NULL
CD3-CD56*	NULL
cells	NULL
were	NULL
due	NULL
to	NULL
contaminating	NULL
CD3+*	NULL
cells	NULL
Complete	NULL
VBS-DJ	NULL
rearrangements	NULL
were	NULL
not	NULL
detectable	NULL
in	NULL
any	NULL
subpopulation	NULL
tested	NULL
,	NULL
except	NULL
in	NULL
total	NULL
thymocytes	NULL
(	NULL
Figure	NULL
7	NULL
,	NULL
third	NULL
panel	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
only	NULL
a	NULL
small	NULL
minority	NULL
of	NULL
the	NULL
starting	NULL
CD4	NULL
ISP	NULL
cells	NULL
have	NULL
TCRB	NULL
gene	NULL
rearrangements	NULL
(	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

It	NULL
is	NULL
of	NULL
note	NULL
that	NULL
CD3-CD56+*	NULL
NK	NULL
cells	NULL
obtained	NULL
from	NULL
cytokine-induced	NULL
CD34*	NULL
fetal	NULL
liver	NULL
cells	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
CD1aCD34+*	NULL
thymocytes	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
did	NULL
not	NULL
have	NULL
rearrangements	NULL
at	NULL
either	NULL
the	NULL
TCR6	NULL
or	NULL
TCRB	NULL
locus	NULL
.	NULL

To	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
Id3	NULL
induces	NULL
rearrangements	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
we	NULL
analyzed	NULL
NK	NULL
cells	NULL
obtained	NULL
from	NULL
an	NULL
FTOC	NULL
which	NULL
was	NULL
seeded	NULL
with	NULL
Id3-transduced	NULL
CD34*	NULL
fetal	NULL
liver	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
CD34*	NULL
FL	NULL
cells	NULL
do	NULL
not	NULL
have	NULL
rearranged	NULL
TCR	NULL
gene	NULL
segments	NULL
(	NULL
Jaleco	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
incubation	NULL
of	NULL
Id3-transduced	NULL
CD34Â¢~	NULL
FL	NULL
cells	NULL
gives	NULL
rise	NULL
to	NULL
many	NULL
NK	NULL
cells	NULL
in	NULL
an	NULL
FTOC	NULL
(	NULL
Heemskerk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

These	NULL
Id3-GFP*CD56+	NULL
NK	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
cells	NULL
expanded	NULL
in	NULL
a	NULL
feeder	NULL
cell	NULL
mixture	NULL
,	NULL
and	NULL
Figure	NULL
7	NULL
shows	NULL
that	NULL
they	NULL
had	NULL
no	NULL
rearranged	NULL
TCR	NULL
genes	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
rearrangements	NULL
of	NULL
the	NULL
V82	NULL
gene	NULL
segment	NULL
,	NULL
which	NULL
are	NULL
associated	NULL
with	NULL
fetal	NULL
T	NULL
cell	NULL
development	NULL
(	NULL
Krangel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
were	NULL
undetectable	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Discussion	NULL
Recently	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
enforced	NULL
expression	NULL
of	NULL
Id3	NULL
in	NULL
human	NULL
CD34Â¢	NULL
fetal	NULL
liver	NULL
cells	NULL
results	NULL
in	NULL
a	NULL
complete	NULL
inhibition	NULL
of	NULL
TCRaB	NULL
and	NULL
TCRYy8	NULL
cell	NULL
development	NULL
and	NULL
a	NULL
developmental	NULL
arrest	NULL
of	NULL
cells	NULL
at	NULL
the	NULL
CD1a~	NULL
CD5*	NULL
stage	NULL
(	NULL
Heemskerk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
these	NULL
CDI1aCD5+*	NULL
cells	NULL
selectively	NULL
differentiate	NULL
into	NULL
CD3~	NULL
CD56+*	NULL
cells	NULL
that	NULL
display	NULL
NK	NULL
cell	NULL
activity	NULL
(	NULL
Heemskerk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
bHLH	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
commitment	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
at	NULL
the	NULL
T/NK	NULL
branch	NULL
point	NULL
.	NULL

We	NULL
now	NULL
demonstrate	NULL
that	NULL
overexpression	NULL
of	NULL
Id3	NULL
in	NULL
cells	NULL
downstream	NULL
of	NULL
this	NULL
branchpoint	NULL
strongly	NULL
inhibits	NULL
development	NULL
of	NULL
TCRB	NULL
T	NULL
cells	NULL
,	NULL
while	NULL
that	NULL
of	NULL
TCRYy8	NULL
cells	NULL
is	NULL
not	NULL
inhibited	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
strong	NULL
inhibition	NULL
of	NULL
TCRYy8	NULL
cell	NULL
development	NULL
following	NULL
Id3	NULL
expression	NULL
in	NULL
CD34Â¢*	NULL
fetal	NULL
liver	NULL
cells	NULL
or	NULL
in	NULL
CD1a	NULL
CD34*	NULL
thymocytes	NULL
that	NULL
represent	NULL
stages	NULL
before	NULL
the	NULL
T/NK	NULL
split	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
and	NULL
indicate	NULL
that	NULL
bHLH	NULL
factors	NULL
continue	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
TCR	NULL
Â«	NULL
f	NULL
development	NULL
beyond	NULL
the	NULL
T/NK	NULL
branchpoint	NULL
.	NULL

One	NULL
possible	NULL
explanation	NULL
for	NULL
our	NULL
observations	NULL
is	NULL
that	NULL
Id3	NULL
overexpression	NULL
interferes	NULL
with	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
.	NULL

This	NULL
may	NULL
be	NULL
one	NULL
mechanism	NULL
through	NULL
which	NULL
1Id3	NULL
inhibits	NULL
development	NULL
of	NULL
uncommitted	NULL
progenitors	NULL
into	NULL
GB	NULL
and	NULL
Y8	NULL
T	NULL
cells	NULL
.	NULL

Data	NULL
from	NULL
our	NULL
previous	NULL
study	NULL
indicate	NULL
that	NULL
Id3	NULL
overexpression	NULL
in	NULL
CD1a	NULL
CD34+*	NULL
thymocytes	NULL
cultured	NULL
in	NULL
IL-7	NULL
prevented	NULL
the	NULL
appearance	NULL
of	NULL
cells	NULL
with	NULL
TCRB	NULL
DJ	NULL
Control	NULL
of	NULL
T	NULL
cell	NULL
development	NULL
by	NULL
bHLH	NULL
proteins	NULL
gene	NULL
rearrangements	NULL
(	NULL
Heemskerk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
Id3	NULL
overexpression	NULL
also	NULL
prevents	NULL
the	NULL
appearance	NULL
of	NULL
cells	NULL
with	NULL
TCR	NULL
rearrangements	NULL
in	NULL
CD1a~	NULL
CD34	NULL
*	NULL
cells	NULL
cultured	NULL
in	NULL
IL-7	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
inhibition	NULL
of	NULL
upregulation	NULL
of	NULL
RAG1	NULL
and	NULL
RAG2	NULL
in	NULL
cells	NULL
overexpressing	NULL
Id3	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
are	NULL
directly	NULL
affected	NULL
by	NULL
Id3	NULL
overexpression	NULL
.	NULL

Since	NULL
TCR	NULL
rearrangements	NULL
commence	NULL
at	NULL
a	NULL
stage	NULL
downstream	NULL
of	NULL
the	NULL
CD4	NULL
ISP	NULL
stage	NULL
,	NULL
in	NULL
the	NULL
DP	NULL
population	NULL
(	NULL
Ramiro	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Verschuren	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
,	NULL
continued	NULL
recombinatorial	NULL
activity	NULL
is	NULL
required	NULL
for	NULL
development	NULL
of	NULL
CD4	NULL
ISP	NULL
cells	NULL
into	NULL
TCRafB	NULL
cells	NULL
.	NULL

One	NULL
can	NULL
,	NULL
therefore	NULL
,	NULL
hypothesize	NULL
that	NULL
Id3	NULL
overexpression	NULL
in	NULL
CD4	NULL
ISP	NULL
cells	NULL
blocks	NULL
TCR	NULL
@	NULL
RB	NULL
cell	NULL
development	NULL
by	NULL
inhibiting	NULL
completion	NULL
of	NULL
and	NULL
initiation	NULL
of	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
.	NULL

The	NULL
failure	NULL
of	NULL
Id3	NULL
to	NULL
inhibit	NULL
development	NULL
of	NULL
CD4	NULL
ISP	NULL
cells	NULL
may	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
these	NULL
cells	NULL
contain	NULL
complete	NULL
TCR8	NULL
and	NULL
y	NULL
gene	NULL
rearrangements	NULL
(	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
data	NULL
do	NULL
not	NULL
preclude	NULL
that	NULL
Id3	NULL
overexpression	NULL
in	NULL
uncommitted	NULL
T	NULL
cell	NULL
progenitors	NULL
results	NULL
in	NULL
a	NULL
developmental	NULL
arrest	NULL
at	NULL
the	NULL
stage	NULL
that	NULL
initiates	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
and	NULL
does	NULL
not	NULL
affect	NULL
recombinations	NULL
directly	NULL
.	NULL

The	NULL
observed	NULL
strong	NULL
inhibition	NULL
of	NULL
pTG	NULL
expression	NULL
by	NULL
Id3	NULL
overexpression	NULL
suggests	NULL
another	NULL
,	NULL
perhaps	NULL
more	NULL
likely	NULL
,	NULL
manner	NULL
in	NULL
which	NULL
Id3	NULL
may	NULL
differentially	NULL
affect	NULL
TCRaf	NULL
and	NULL
y6	NULL
development	NULL
from	NULL
committed	NULL
pre-T	NULL
cells	NULL
.	NULL

Studies	NULL
with	NULL
pTo-deficient	NULL
mice	NULL
indicate	NULL
that	NULL
this	NULL
gene	NULL
is	NULL
required	NULL
for	NULL
optimal	NULL
development	NULL
of	NULL
TCR	NULL
&	NULL
f	NULL
but	NULL
not	NULL
of	NULL
TCRYy8	NULL
cells	NULL
(	NULL
Fehling	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
the	NULL
CD4	NULL
ISP	NULL
stage	NULL
is	NULL
upstream	NULL
of	NULL
the	NULL
f	NULL
}	NULL
selection	NULL
checkpoint	NULL
(	NULL
Ramiro	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
tempting	NULL
to	NULL
hypothesize	NULL
that	NULL
enforced	NULL
expression	NULL
of	NULL
Id3	NULL
in	NULL
CD4	NULL
ISP	NULL
cells	NULL
leads	NULL
to	NULL
downregulation	NULL
of	NULL
pTC	NULL
and	NULL
thereby	NULL
inhibits	NULL
the	NULL
proliferation	NULL
that	NULL
accompanies	NULL
B	NULL
selection	NULL
.	NULL

This	NULL
may	NULL
contribute	NULL
to	NULL
or	NULL
perhaps	NULL
be	NULL
completely	NULL
responsible	NULL
for	NULL
the	NULL
observed	NULL
inhibition	NULL
of	NULL
TCRafB	NULL
development	NULL
.	NULL

It	NULL
is	NULL
unclear	NULL
whether	NULL
bHLH	NULL
factors	NULL
directly	NULL
affect	NULL
pTo	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
promotor	NULL
region	NULL
of	NULL
pT	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
characterized	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
bHLH	NULL
protein	NULL
E47	NULL
has	NULL
been	NULL
shown	NULL
directly	NULL
to	NULL
control	NULL
expression	NULL
of	NULL
the	NULL
surrogate	NULL
light	NULL
chain	NULL
genes	NULL
,	NULL
the	NULL
equivalents	NULL
of	NULL
pTo	NULL
in	NULL
B	NULL
cell	NULL
progenitors	NULL
(	NULL
Sigvardsson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
hypothesis	NULL
that	NULL
Id3	NULL
impedes	NULL
T	NULL
cell	NULL
development	NULL
either	NULL
by	NULL
affecting	NULL
TCR	NULL
rearrangements	NULL
or	NULL
expression	NULL
or	NULL
both	NULL
does	NULL
not	NULL
explain	NULL
the	NULL
observation	NULL
that	NULL
Id3	NULL
overexpression	NULL
in	NULL
CD1atCD34+*	NULL
and	NULL
CD4	NULL
ISP	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
CD1aCD3-CD4-CD5Â¢*	NULL
cells	NULL
in	NULL
an	NULL
FTOC	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
never	NULL
observed	NULL
in	NULL
FTOCs	NULL
with	NULL
untransduced	NULL
or	NULL
control	NULL
GFP-transduced	NULL
or	NULL
CD4	NULL
ISP	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
considered	NULL
the	NULL
possibility	NULL
that	NULL
once	NULL
T	NULL
cell	NULL
development	NULL
is	NULL
aborted	NULL
,	NULL
downregulation	NULL
of	NULL
CD1a	NULL
and	NULL
CD4	NULL
and	NULL
acquisition	NULL
of	NULL
some	NULL
NK	NULL
markers	NULL
occurs	NULL
by	NULL
default	NULL
in	NULL
our	NULL
FTOC	NULL
system	NULL
.	NULL

This	NULL
is	NULL
unlikely	NULL
since	NULL
enforced	NULL
expression	NULL
of	NULL
constitutively	NULL
active	NULL
p56	NULL
in	NULL
CD4	NULL
ISP	NULL
cells	NULL
strongly	NULL
inhibited	NULL
T	NULL
cell	NULL
development	NULL
,	NULL
but	NULL
did	NULL
not	NULL
result	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
CD1a	NULL
~CD3-CD4~	NULL
CD5	NULL
*	NULL
cells	NULL
in	NULL
an	NULL
FTOC	NULL
(	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
CD1aCD3-CD4-CDS5~*	NULL
cells	NULL
appear	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
Id3	NULL
overexpression	NULL
in	NULL
CD4	NULL
ISP	NULL
cells	NULL
.	NULL

These	NULL
cells	NULL
could	NULL
be	NULL
expanded	NULL
following	NULL
culture	NULL
in	NULL
a	NULL
feeder	NULL
cell	NULL
mixture	NULL
containing	NULL
IL-2	NULL
.	NULL

A	NULL
large	NULL
proportion	NULL
of	NULL
the	NULL
CD3~	NULL
cells	NULL
in	NULL
these	NULL
cultures	NULL
expressed	NULL
NK	NULL
markers	NULL
such	NULL
as	NULL
CD56	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
and	NULL
CD94	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
2799	NULL
B.Blom	NULL
et	NULL
al	NULL
.	NULL

and	NULL
displayed	NULL
cytotoxic	NULL
activity	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
CD4	NULL
ISP	NULL
cells	NULL
have	NULL
>	NULL
95	NULL
%	NULL
and	NULL
15	NULL
%	NULL
of	NULL
the	NULL
TCR	NULL
and	NULL
[	NULL
}	NULL
alleles	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
rearranged	NULL
form	NULL
(	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
,	NULL
the	NULL
CD1aCD3-CD4-CD56+	NULL
cells	NULL
derived	NULL
from	NULL
CD4	NULL
ISP	NULL
cells	NULL
contain	NULL
TCR68	NULL
and	NULL
a	NULL
low	NULL
level	NULL
of	NULL
TCRB	NULL
gene	NULL
rearrangements	NULL
.	NULL

Thus	NULL
these	NULL
cells	NULL
have	NULL
NK	NULL
characteristics	NULL
but	NULL
they	NULL
retained	NULL
properties	NULL
of	NULL
pre-T	NULL
cells	NULL
.	NULL

Since	NULL
the	NULL
expanded	NULL
cells	NULL
have	NULL
TCR	NULL
rearrangements	NULL
but	NULL
fail	NULL
to	NULL
express	NULL
a	NULL
TCR	NULL
on	NULL
the	NULL
cell	NULL
membrane	NULL
,	NULL
we	NULL
should	NULL
assume	NULL
that	NULL
the	NULL
observed	NULL
TCR	NULL
rearrangements	NULL
were	NULL
unproductive	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
bHLH	NULL
factors	NULL
in	NULL
CD3~	NULL
pre-T	NULL
cells	NULL
prevent	NULL
the	NULL
loss	NULL
of	NULL
CD1a	NULL
and	NULL
CD4	NULL
and	NULL
acquisition	NULL
of	NULL
the	NULL
capacity	NULL
to	NULL
respond	NULL
to	NULL
IL-2	NULL
before	NULL
completion	NULL
of	NULL
TCR	NULL
rearrangements	NULL
.	NULL

The	NULL
loss	NULL
of	NULL
CD1a	NULL
,	NULL
CD4	NULL
and	NULL
CD8	NULL
and	NULL
the	NULL
acquisition	NULL
of	NULL
NK	NULL
markers	NULL
on	NULL
cells	NULL
that	NULL
develop	NULL
from	NULL
Id3-transduced	NULL
CD4	NULL
ISP	NULL
cells	NULL
strongly	NULL
suggest	NULL
that	NULL
Id3	NULL
overexpression	NULL
may	NULL
result	NULL
in	NULL
a	NULL
change	NULL
of	NULL
cell	NULL
fate	NULL
of	NULL
some	NULL
cells	NULL
from	NULL
the	NULL
T	NULL
into	NULL
the	NULL
NK	NULL
cell	NULL
lineage	NULL
.	NULL

Experiments	NULL
to	NULL
test	NULL
this	NULL
interesting	NULL
possibility	NULL
are	NULL
under	NULL
way	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
bHLH	NULL
factors	NULL
that	NULL
are	NULL
critical	NULL
for	NULL
T	NULL
cell	NULL
development	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
precisely	NULL
.	NULL

Using	NULL
an	NULL
RT-PCR	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
early	NULL
T	NULL
cell	NULL
progenitors	NULL
in	NULL
the	NULL
human	NULL
thymus	NULL
express	NULL
E12	NULL
,	NULL
E47	NULL
,	NULL
HEB	NULL
as	NULL
well	NULL
as	NULL
Id1	NULL
and	NULL
Id3	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
EZ2A	NULL
and	NULL
HEB	NULL
proteins	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

E2A	NULL
deficiency	NULL
results	NULL
in	NULL
a	NULL
partial	NULL
block	NULL
in	NULL
T	NULL
cell	NULL
differentiation	NULL
at	NULL
the	NULL
transition	NULL
of	NULL
CD44*CD25~	NULL
cells	NULL
into	NULL
CD44Â®CD25+*	NULL
cells	NULL
(	NULL
Bain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19972	NULL
)	NULL
.	NULL

The	NULL
CD25~-	NULL
to	NULL
CD25	NULL
*	NULL
transition	NULL
is	NULL
roughly	NULL
equivalent	NULL
to	NULL
the	NULL
CD1a~	NULL
to	NULL
CD1a*	NULL
transition	NULL
in	NULL
humans	NULL
(	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
,	NULL
Spits	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Mice	NULL
deficient	NULL
for	NULL
another	NULL
bHLH	NULL
protein	NULL
,	NULL
HEB	NULL
,	NULL
have	NULL
perturbed	NULL
T	NULL
cell	NULL
development	NULL
with	NULL
a	NULL
relative	NULL
accumulation	NULL
of	NULL
double	NULL
negative	NULL
and	NULL
CD3-CD4-CD8*	NULL
cells	NULL
in	NULL
the	NULL
thymus	NULL
(	NULL
Zhuang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Since	NULL
no	NULL
further	NULL
analysis	NULL
of	NULL
thymocytes	NULL
from	NULL
HEB-deficient	NULL
mice	NULL
has	NULL
been	NULL
reported	NULL
(	NULL
Zhuang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
the	NULL
exact	NULL
T	NULL
cell	NULL
developmental	NULL
stage	NULL
that	NULL
is	NULL
affected	NULL
in	NULL
these	NULL
mice	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
sequestration	NULL
of	NULL
EZ2A	NULL
proteins	NULL
by	NULL
1d3	NULL
is	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
responsible	NULL
for	NULL
the	NULL
block	NULL
in	NULL
T	NULL
cell	NULL
differentiation	NULL
observed	NULL
following	NULL
overexpression	NULL
of	NULL
Id3	NULL
.	NULL

It	NULL
seems	NULL
likely	NULL
,	NULL
however	NULL
,	NULL
that	NULL
other	NULL
bHLH	NULL
factors	NULL
are	NULL
implicated	NULL
as	NULL
well	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
here	NULL
provide	NULL
evidence	NULL
that	NULL
control	NULL
of	NULL
T	NULL
cell	NULL
commitment	NULL
beyond	NULL
the	NULL
T/NK	NULL
checkpoint	NULL
and	NULL
completion	NULL
of	NULL
development	NULL
of	NULL
committed	NULL
pre-T	NULL
cells	NULL
into	NULL
TCRB	NULL
cells	NULL
require	NULL
the	NULL
continued	NULL
activities	NULL
of	NULL
bHLH	NULL
factors	NULL
.	NULL

The	NULL
power	NULL
of	NULL
the	NULL
retroviral	NULL
system	NULL
is	NULL
also	NULL
clearly	NULL
demonstrated	NULL
here	NULL
.	NULL

Not	NULL
only	NULL
does	NULL
this	NULL
technology	NULL
offer	NULL
a	NULL
way	NULL
to	NULL
genetically	NULL
modify	NULL
human	NULL
T	NULL
cell	NULL
development	NULL
,	NULL
it	NULL
also	NULL
has	NULL
advantages	NULL
on	NULL
its	NULL
own	NULL
.	NULL

The	NULL
most	NULL
important	NULL
one	NULL
is	NULL
that	NULL
genes	NULL
can	NULL
be	NULL
introduced	NULL
before	NULL
or	NULL
after	NULL
defined	NULL
checkpoints	NULL
of	NULL
development	NULL
of	NULL
individual	NULL
lineages	NULL
.	NULL

Taking	NULL
advantage	NULL
of	NULL
this	NULL
feature	NULL
,	NULL
one	NULL
can	NULL
analyze	NULL
functions	NULL
of	NULL
genes	NULL
in	NULL
a	NULL
way	NULL
that	NULL
can	NULL
not	NULL
yet	NULL
be	NULL
achieved	NULL
easily	NULL
using	NULL
knock-out	NULL
or	NULL
transgenic	NULL
technologies	NULL
.	NULL

Application	NULL
of	NULL
this	NULL
technology	NULL
to	NULL
the	NULL
mouse	NULL
system	NULL
and	NULL
combining	NULL
this	NULL
with	NULL
knock-out	NULL
technologies	NULL
will	NULL
greatly	NULL
extend	NULL
the	NULL
ability	NULL
to	NULL
analyze	NULL
the	NULL
mechanisms	NULL
of	NULL
lymphoid	NULL
development	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Isolation	NULL
of	NULL
subpopulations	NULL
from	NULL
thymus	NULL
Normal	NULL
human	NULL
thymocytes	NULL
were	NULL
obtained	NULL
from	NULL
thymus	NULL
fragments	NULL
removed	NULL
during	NULL
corrective	NULL
cardiac	NULL
surgery	NULL
of	NULL
patients	NULL
aged	NULL
1	NULL
month	NULL
to	NULL
2800	NULL
2	NULL
years	NULL
.	NULL

Thymic	NULL
lobes	NULL
were	NULL
minced	NULL
gently	NULL
in	NULL
RPMI-1640	NULL
(	NULL
Gibco-BRL	NULL
Life	NULL
Technologies	NULL
Ltd	NULL
,	NULL
Paisley	NULL
,	NULL
UK	NULL
)	NULL
containing	NULL
2	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
BioWhittaker	NULL
,	NULL
Verviers	NULL
,	NULL
Belgium	NULL
)	NULL
and	NULL
antibiotics	NULL
(	NULL
penicillin	NULL
500	NULL
IU/ml	NULL
,	NULL
streptomycin	NULL
100	NULL
mg/ml	NULL
,	NULL
Boehringer	NULL
Mannheim	NULL
Biochemicals	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll	NULL
density	NULL
gradient	NULL
centrifugation	NULL
(	NULL
Lymphoprep	NULL
,	NULL
1.077	NULL
g/ml	NULL
,	NULL
Nycomed	NULL
Pharma	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
.	NULL

Thymocytes	NULL
recovered	NULL
from	NULL
the	NULL
Ficoll	NULL
interface	NULL
were	NULL
enriched	NULL
for	NULL
CD34	NULL
*	NULL
cells	NULL
using	NULL
a	NULL
kit	NULL
for	NULL
separation	NULL
of	NULL
CD34*	NULL
cells	NULL
and	NULL
a	NULL
miniMACS	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
Inc.	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Cells	NULL
were	NULL
sorted	NULL
after	NULL
staining	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
mAbs	NULL
)	NULL
against	NULL
molecular	NULL
epitopes	NULL
different	NULL
from	NULL
those	NULL
recognized	NULL
by	NULL
the	NULL
mAbs	NULL
used	NULL
during	NULL
the	NULL
miniMACS	NULL
procedures	NULL
.	NULL

For	NULL
cell	NULL
sorting	NULL
of	NULL
CD1a	NULL
CD34	NULL
*	NULL
and	NULL
CD1a*CD34*	NULL
subpopulations	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
ul/10Â°	NULL
cells	NULL
of	NULL
CD34-fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
(	NULL
HPCA-2	NULL
,	NULL
Becton	NULL
Dickinson	NULL
&	NULL
Co.	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
0.5	NULL
pJ/lO6	NULL
cells	NULL
of	NULL
CD1a-phecoerythrin	NULL
(	NULL
PE	NULL
)	NULL
(	NULL
T6-RD1	NULL
,	NULL
Coulter	NULL
Clone	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
at	NULL
4Â°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

To	NULL
enrich	NULL
for	NULL
CD4	NULL
ISP	NULL
cells	NULL
,	NULL
total	NULL
thymocytes	NULL
were	NULL
depleted	NULL
twice	NULL
with	NULL
CD27	NULL
mAb	NULL
[	NULL
9F4	NULL
,	NULL
gift	NULL
from	NULL
Dr	NULL
R.van	NULL
Lier	NULL
,	NULL
Central	NULL
Laboratory	NULL
of	NULL
Blood	NULL
transfusion	NULL
(	NULL
CLB	NULL
)	NULL
,	NULL
Amsterdam	NULL
]	NULL
,	NULL
CD69	NULL
mAb	NULL
(	NULL
L78	NULL
,	NULL
provided	NULL
by	NULL
Dr	NULL
J.H.Phillips	NULL
,	NULL
DNAX	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
magnetic	NULL
beads	NULL
(	NULL
Dynabeads	NULL
,	NULL
Dynal	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
.	NULL

The	NULL
depleted	NULL
thymocytes	NULL
were	NULL
stained	NULL
with	NULL
CD4-PE	NULL
(	NULL
Leu3a	NULL
,	NULL
Becton	NULL
Dickinson	NULL
)	NULL
,	NULL
CD3-FITC	NULL
(	NULL
Leuda	NULL
)	NULL
,	NULL
and	NULL
CD8	NULL
@	NULL
-tricolor	NULL
(	NULL
TRC	NULL
;	NULL
3B5	NULL
,	NULL
Caltag	NULL
Laboratories	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
sorted	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
CD4*CD3-CD8~	NULL
expression	NULL
.	NULL

Cells	NULL
were	NULL
isolated	NULL
by	NULL
fluorescence	NULL
activated	NULL
cell	NULL
sorting	NULL
on	NULL
a	NULL
FACStar	NULL
Plus	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
equipped	NULL
with	NULL
an	NULL
argon	NULL
laser	NULL
emitting	NULL
at	NULL
488	NULL
nm	NULL
.	NULL

During	NULL
the	NULL
sorting	NULL
procedure	NULL
,	NULL
cells	NULL
were	NULL
kept	NULL
at	NULL
4Â°C	NULL
.	NULL

All	NULL
fractions	NULL
used	NULL
in	NULL
the	NULL
subsequent	NULL
experiments	NULL
were	NULL
reanalyzed	NULL
after	NULL
sorting	NULL
and	NULL
contained	NULL
>	NULL
99	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
selected	NULL
sort	NULL
gates	NULL
.	NULL

Retroviral	NULL
constructs	NULL
and	NULL
transduction	NULL
A	NULL
LZRS	NULL
retroviral	NULL
vector	NULL
was	NULL
constructed	NULL
comprising	NULL
the	NULL
Id3	NULL
cDNA	NULL
(	NULL
generous	NULL
gift	NULL
of	NULL
Dr	NULL
C.	NULL
Murre	NULL
,	NULL
UCSD	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
the	NULL
enhanced	NULL
GFP	NULL
(	NULL
obtained	NULL
from	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
a	NULL
marker	NULL
gene	NULL
.	NULL

The	NULL
cDNAs	NULL
were	NULL
separated	NULL
by	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
IRES	NULL
in	NULL
order	NULL
to	NULL
allow	NULL
individual	NULL
translation	NULL
of	NULL
the	NULL
bicistronic	NULL
mRNA	NULL
containing	NULL
both	NULL
Id3	NULL
and	NULL
GFP	NULL
(	NULL
Id3-IRES-GFP	NULL
)	NULL
without	NULL
generating	NULL
a	NULL
fusion	NULL
protein	NULL
(	NULL
Davies	NULL
and	NULL
Kaufman	NULL
,	NULL
1992	NULL
;	NULL
Pestova	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Sachs	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
we	NULL
made	NULL
a	NULL
retroviral	NULL
vector	NULL
containing	NULL
the	NULL
IRES-GFP	NULL
sequence	NULL
only	NULL
(	NULL
IRES-GEP	NULL
)	NULL
.	NULL

Helper	NULL
virus-free	NULL
recombinant	NULL
retroviruses	NULL
(	NULL
titre	NULL
10Â°/ml	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
transduction	NULL
of	NULL
mouse	NULL
3T3	NULL
fibroblast	NULL
cells	NULL
)	NULL
were	NULL
produced	NULL
after	NULL
transfection	NULL
of	NULL
the	NULL
retroviral	NULL
constructs	NULL
into	NULL
the	NULL
293T-based	NULL
@	NULL
NX-A	NULL
amphotropic	NULL
packaging	NULL
cell	NULL
line	NULL
(	NULL
Kinsella	NULL
and	NULL
Nolan	NULL
,	NULL
1996	NULL
)	NULL
(	NULL
provided	NULL
by	NULL
Dr	NULL
G.Nolan	NULL
,	NULL
Stanford	NULL
University	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
selection	NULL
on	NULL
puromycin	NULL
.	NULL

Progenitor	NULL
cells	NULL
were	NULL
purified	NULL
from	NULL
thymus	NULL
and	NULL
cultured	NULL
overnight	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
ng/ml	NULL
IL-7	NULL
(	NULL
R	NULL
&	NULL
D	NULL
systems	NULL
,	NULL
Abingdon	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
10	NULL
ng/ml	NULL
SCF	NULL
(	NULL
R	NULL
&	NULL
D	NULL
)	NULL
followed	NULL
by	NULL
incubation	NULL
for	NULL
7-8	NULL
h	NULL
or	NULL
overnight	NULL
with	NULL
virus	NULL
supernatant	NULL
in	NULL
plates	NULL
coated	NULL
with	NULL
30	NULL
ug/ml	NULL
recombinant	NULL
human	NULL
fibronectin	NULL
fragment	NULL
CH-296	NULL
(	NULL
RetroNectin	NULL
'	NULL
``	NULL
;	NULL
Takara	NULL
,	NULL
Otsu	NULL
,	NULL
Japan	NULL
)	NULL
(	NULL
Kimizuka	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Hanenberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Hybrid	NULL
human-mouse	NULL
fetal	NULL
thymic	NULL
organ	NULL
cultures	NULL
The	NULL
in	NULL
vitro	NULL
development	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
from	NULL
CD1a*CD34*	NULL
and	NULL
CD4	NULL
ISP	NULL
progenitor	NULL
cells	NULL
was	NULL
studied	NULL
using	NULL
the	NULL
hybrid	NULL
human-mouse	NULL
FTOC	NULL
(	NULL
Res	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Fetal	NULL
thymuses	NULL
were	NULL
obtained	NULL
from	NULL
embryos	NULL
of	NULL
RAG1-deficient	NULL
mice	NULL
on	NULL
day	NULL
15-16	NULL
of	NULL
gestation	NULL
.	NULL

The	NULL
lobes	NULL
were	NULL
treated	NULL
with	NULL
1.35	NULL
mM	NULL
deoxyguanosine	NULL
(	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
for	NULL
5	NULL
days	NULL
before	NULL
incubation	NULL
with	NULL
human	NULL
progenitor	NULL
cells	NULL
in	NULL
a	NULL
hanging	NULL
drop	NULL
culture	NULL
for	NULL
2	NULL
days	NULL
followed	NULL
by	NULL
incubation	NULL
on	NULL
an	NULL
air-liquid	NULL
interface	NULL
.	NULL

Culture	NULL
medium	NULL
consisted	NULL
of	NULL
Yssel	NULL
's	NULL
medium	NULL
(	NULL
Yssel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
supplemented	NULL
with	NULL
2	NULL
%	NULL
normal	NULL
human	NULL
serum	NULL
and	NULL
5	NULL
%	NULL
FCS	NULL
.	NULL

To	NULL
analyze	NULL
differentiation	NULL
of	NULL
human	NULL
cells	NULL
,	NULL
the	NULL
thymuses	NULL
were	NULL
dispersed	NULL
into	NULL
single	NULL
cell	NULL
suspensions	NULL
and	NULL
stained	NULL
with	NULL
mAbs	NULL
specific	NULL
for	NULL
human	NULL
cell	NULL
surface	NULL
antigens	NULL
.	NULL

Expansion	NULL
cultures	NULL
Cells	NULL
recovered	NULL
from	NULL
the	NULL
FTOC	NULL
were	NULL
expanded	NULL
at	NULL
a	NULL
cell	NULL
density	NULL
of	NULL
3X10	NULL
%	NULL
/ml	NULL
in	NULL
Yssel	NULL
's	NULL
medium	NULL
containing	NULL
a	NULL
mixture	NULL
of	NULL
irradiated	NULL
PBMC	NULL
(	NULL
10	NULL
%	NULL
/ml	NULL
;	NULL
3000	NULL
rad	NULL
)	NULL
,	NULL
the	NULL
EBV	NULL
cell	NULL
line	NULL
JY	NULL
(	NULL
10Â°/ml	NULL
;	NULL
5000	NULL
rad	NULL
)	NULL
,	NULL
PHA	NULL
(	NULL
100	NULL
ng/ml	NULL
:	NULL
Murex	NULL
Diagnostics	NULL
Ltd	NULL
,	NULL
Dartford	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
IL-2	NULL
(	NULL
20	NULL
IU/ml	NULL
;	NULL
Chiron	NULL
,	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
we	NULL
can	NULL
expand	NULL
NK	NULL
cells	NULL
and	NULL
y8*	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
Â«	NULL
B*	NULL
T	NULL
cells	NULL
from	NULL
an	NULL
FTOC	NULL
(	NULL
Res	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
GFP-transduced	NULL
human	NULL
cells	NULL
recovered	NULL
from	NULL
the	NULL
hybrid	NULL
mouse	NULL
FTOC	NULL
cultures	NULL
were	NULL
analyzed	NULL
by	NULL
three-color	NULL
flow	NULL
cytometric	NULL
analysis	NULL
on	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
after	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
with	NULL
the	NULL
following	NULL
antibodies	NULL
conjugated	NULL
with	NULL
the	NULL
fluorochromes	NULL
PE	NULL
or	NULL
TRC	NULL
:	NULL
CD3	NULL
(	NULL
Leu-4	NULL
)	NULL
,	NULL
CD4	NULL
(	NULL
Leu-3a	NULL
)	NULL
,	NULL
CD8	NULL
(	NULL
Leu-2	NULL
)	NULL
,	NULL
CD2	NULL
(	NULL
Leu-5b	NULL
)	NULL
,	NULL
CD7	NULL
(	NULL
Leu-9	NULL
)	NULL
,	NULL
CD5	NULL
(	NULL
Leu-1	NULL
)	NULL
,	NULL
CD45RA	NULL
(	NULL
Leu-18	NULL
)	NULL
(	NULL
all	NULL
from	NULL
Becton	NULL
Dickinson	NULL
)	NULL
,	NULL
anti-TCRaB	NULL
and	NULL
anti-TCRYyÂ§	NULL
(	NULL
Immunotech	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
)	NULL
,	NULL
CD56	NULL
(	NULL
NCAM	NULL
16.2	NULL
,	NULL
Becton	NULL
Dickinson	NULL
)	NULL
and	NULL
CD1a	NULL
(	NULL
T6-RD1	NULL
,	NULL
Coulter	NULL
Clone	NULL
)	NULL
.	NULL

Data	NULL
were	NULL
analyzed	NULL
with	NULL
the	NULL
Cell	NULL
Quest	NULL
program	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

RT-PCR	NULL
assays	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
flow	NULL
cytometric-sorted	NULL
human	NULL
postnatal	NULL
thymocyte	NULL
subpopulations	NULL
using	NULL
TRIzol	NULL
reagent	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
and	NULL
reverse	NULL
transcribed	NULL
using	NULL
a	NULL
poly	NULL
(	NULL
dT	NULL
)	NULL
;	NULL
s	NULL
oligonucleotide	NULL
and	NULL
400	NULL
U	NULL
of	NULL
M-MuLV	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
at	NULL
37Â°C	NULL
for	NULL
1	NULL
h.	NULL
Semi-quantitative	NULL
RT-PCR	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Blom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

PCR	NULL
assays	NULL
were	NULL
done	NULL
in	NULL
30	NULL
pil	NULL
reaction	NULL
volumes	NULL
using	NULL
the	NULL
appropriate	NULL
diluted	NULL
amounts	NULL
of	NULL
cDNA	NULL
template	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.25	NULL
mM	NULL
each	NULL
dNTP	NULL
,	NULL
10	NULL
pmol	NULL
of	NULL
each	NULL
primer	NULL
and	NULL
0.8	NULL
U	NULL
of	NULL
Taq	NULL
polymerase	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
in	NULL
1X	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
]	NULL
pH	NULL
8.5	NULL
,	NULL
50	NULL
mM	NULL
KC	NULL
]	NULL
.	NULL

Reaction	NULL
conditions	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
5	NULL
min	NULL
denaturing	NULL
step	NULL
at	NULL
95Â°C	NULL
followed	NULL
by	NULL
31	NULL
cycles	NULL
of	NULL
1	NULL
min	NULL
at	NULL
95Â°C	NULL
,	NULL
1	NULL
min	NULL
at	NULL
55Â°C	NULL
and	NULL
1	NULL
min	NULL
at	NULL
72Â°C	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
,	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
and	NULL
analyzed	NULL
by	NULL
video	NULL
densitometry	NULL
using	NULL
the	NULL
Eagle	NULL
Eye	NULL
still	NULL
video	NULL
system	NULL
and	NULL
Eagle	NULL
Sight	NULL
software	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
RAG1	NULL
,	NULL
RAG2	NULL
,	NULL
pT	NULL
and	NULL
HPRT	NULL
primers	NULL
that	NULL
were	NULL
used	NULL
are	NULL
:	NULL
HPRT	NULL
sense	NULL
,	NULL
5'-TATGGACAGG-ACTGAACGTCTTGC-3	NULL
'	NULL
;	NULL
HPRT	NULL
antisense	NULL
,	NULL
5'-GACACAAACATGAT-TCAAATCCCTGA-3	NULL
'	NULL
;	NULL
RAG1	NULL
-	NULL
sense	NULL
,	NULL
5'-GAACACACTTTGCCT-TCTCTTTGG-3	NULL
'	NULL
;	NULL
RAG1	NULL
antisense	NULL
,	NULL
CGTT-3	NULL
'	NULL
;	NULL
RAG2	NULL
sense	NULL
,	NULL
5	NULL
``	NULL
-TGTGAATTGCACAGTCTTGCCAGG-3	NULL
'	NULL
;	NULL
RAG2	NULL
antisense	NULL
,	NULL
pTa	NULL
sense	NULL
,	NULL
5-GTCCAGCCCTACCCACAGGTGT-3	NULL
'	NULL
;	NULL
and	NULL
pTQ	NULL
antisense	NULL
,	NULL
5-CGGGAATTCGACGTCCCTGGCTGTAGAAGCCTCTC-3	NULL
'	NULL
.	NULL

TCRO	NULL
gene	NULL
rearrangement	NULL
analysis	NULL
by	NULL
PCR	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
were	NULL
analyzed	NULL
by	NULL
using	NULL
DNA	NULL
of	NULL
~10*	NULL
cells	NULL
in	NULL
a	NULL
genomic	NULL
DNA	NULL
PCR	NULL
assay	NULL
.	NULL

Isolation	NULL
of	NULL
DNA	NULL
and	NULL
PCR	NULL
of	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
was	NULL
done	NULL
as	NULL
described	NULL
(	NULL
Breit	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

TCR	NULL
&	NULL
8	NULL
PCR	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
forward	NULL
V8l	NULL
(	NULL
5'-TGAGGAAAGCAGT-CACCCTGAAC-3	NULL
'	NULL
)	NULL
or	NULL
V82	NULL
(	NULL
5'-ACCAAACAGTGCCTGTGTCAAT-AGG-3	NULL
'	NULL
)	NULL
and	NULL
J81	NULL
reverse	NULL
(	NULL
S'-ACCTCTTCCCAGGAGTCCTCC-3	NULL
'	NULL
)	NULL
primers	NULL
.	NULL

TCRB	NULL
D-J	NULL
PCR	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
DBIL.1	NULL
forward	NULL
(	NULL
5'-TGGTGGTCTCTCCCAGGCTCT-3	NULL
'	NULL
)	NULL
and	NULL
JBL.3-1.4	NULL
reverse	NULL
(	NULL
5'-CCA-GCTGTCCAGCCTTGACTT-3	NULL
'	NULL
)	NULL
primers	NULL
.	NULL

A	NULL
10	NULL
pl	NULL
aliquot	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
was	NULL
run	NULL
on	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
followed	NULL
by	NULL
DNA	NULL
transfer	NULL
to	NULL
a	NULL
nylon	NULL
filter	NULL
(	NULL
Hybond	NULL
N*	NULL
,	NULL
Amersham	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
pre-hybridized	NULL
at	NULL
55Â°C	NULL
for	NULL
at	NULL
least	NULL
1	NULL
h	NULL
(	NULL
6X	NULL
SSC	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
5X	NULL
Denhardt	NULL
's	NULL
,	NULL
100	NULL
mg	NULL
herring	NULL
sperm	NULL
DNA	NULL
per	NULL
litre	NULL
)	NULL
and	NULL
hybridized	NULL
overnight	NULL
with	NULL
a	NULL
labeled	NULL
oligoprobe	NULL
specifically	NULL
recognizing	NULL
V81-181	NULL
(	NULL
5'-TGAGGAAA-GCAGTCACCCTGAAC-3	NULL
'	NULL
)	NULL
or	NULL
TCRB	NULL
DfBpan	NULL
(	NULL
5-CAAAGCTGT-AACATTGTGGGGAC-3	NULL
'	NULL
)	NULL
PCR	NULL
products	NULL
internal	NULL
to	NULL
the	NULL
PCR	NULL
primers	NULL
.	NULL

To	NULL
control	NULL
for	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
used	NULL
in	NULL
the	NULL
PCR	NULL
,	NULL
we	NULL
amplified	NULL
the	NULL
RAG2	NULL
gene	NULL
by	NULL
using	NULL
RAG2	NULL
forward	NULL
(	NULL
5-TGTGAATTGCACAGT-CTTGCCAGG-3	NULL
'	NULL
)	NULL
and	NULL
RAG2	NULL
reverse	NULL
(	NULL
5-GGGTITGTTGAGCTCA-GTTGAATAG-3	NULL
``	NULL
)	NULL
primers	NULL
,	NULL
which	NULL
we	NULL
detected	NULL
with	NULL
a	NULL
RAG2	NULL
oligoprobe	NULL
(	NULL
5-CAAGATATGGTTTGGAAGCAACATGGGAAA-3	NULL
'	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
with	NULL
an	NULL
excess	NULL
amount	NULL
of	NULL
2	NULL
%	NULL
X	NULL
SSC	NULL
;	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
50Â°C	NULL
for	NULL
30	NULL
min	NULL
and	NULL
exposed	NULL
to	NULL
an	NULL
autoradiographic	NULL
film	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
Dr	NULL
Ad	NULL
J.J.C.Bogers	NULL
from	NULL
the	NULL
Department	NULL
of	NULL
Thoracic	NULL
Surgery	NULL
from	NULL
the	NULL
Erasmus	NULL
University	NULL
and	NULL
University	NULL
Hospital	NULL
Rotterdam	NULL
for	NULL
postnatal	NULL
thymus	NULL
samples	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Drs	NULL
Gary	NULL
Nolan	NULL
,	NULL
Cees	NULL
Murre	NULL
and	NULL
Ashok	NULL
Venkitaraman	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
the	NULL
@	NULL
NX-A	NULL
packaging	NULL
cell	NULL
line	NULL
,	NULL
the	NULL
Id3	NULL
cDNA	NULL
and	NULL
the	NULL
p56	NULL
``	NULL
cDNA	NULL
,	NULL
respectively	NULL
.	NULL

We	NULL
are	NULL
indebted	NULL
to	NULL
Drs	NULL
Lewis	NULL
Lanier	NULL
,	NULL
Joe	NULL
Phillips	NULL
and	NULL
Rene	NULL
van	NULL
Lier	NULL
for	NULL
making	NULL
antibodies	NULL
available	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
Naomi	NULL
Taylor	NULL
,	NULL
Ada	NULL
M.Kruisbeek	NULL
,	NULL
Jannie	NULL
Borst	NULL
and	NULL
Lewis	NULL
L.Lanier	NULL
for	NULL
critically	NULL
reading	NULL
the	NULL
manuscript	NULL
and	NULL
for	NULL
helpful	NULL
suggestions	NULL
.	NULL

We	NULL
express	NULL
our	NULL
gratitude	NULL
to	NULL
Eric	NULL
Noteboom	NULL
for	NULL
cell	NULL
sorting	NULL
and	NULL
to	NULL
the	NULL
staff	NULL
at	NULL
the	NULL
mouse	NULL
facilities	NULL
of	NULL
the	NULL
Netherlands	NULL
Cancer	NULL
Institute	NULL
for	NULL
maintaining	NULL
the	NULL
pregnant	NULL
RAG1-deficient	NULL
mice	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Netherlands	NULL
Organization	NULL
for	NULL
Scientific	NULL
Research	NULL
(	NULL
NWO	NULL
)	NULL
and	NULL
the	NULL
Dutch	NULL
Cancer	NULL
Society	NULL
.	NULL

References	NULL
Aifantis	NULL
,	NULL
L.	NULL
,	NULL
Azogui	NULL
,	NULL
O.	NULL
,	NULL
Feinberg	NULL
,	NULL
J.	NULL
,	NULL
Saint	NULL
Ruf	NULL
,	NULL
C.	NULL
,	NULL
BuerJ	NULL
.	NULL

and	NULL
von	NULL
Boehmer	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
On	NULL
the	NULL
role	NULL
of	NULL
the	NULL
pre-T	NULL
cell	NULL
receptor	NULL
in	NULL
(	NULL
B	NULL
versus	NULL
y6	NULL
T	NULL
lineage	NULL
commitment	NULL
.	NULL

Immunity	NULL
,	NULL
9	NULL
,	NULL
649-655	NULL
.	NULL

Control	NULL
of	NULL
T	NULL
cell	NULL
development	NULL
by	NULL
bHLH	NULL
proteins	NULL
Bain	NULL
,	NULL
G	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
E2A	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
initiation	NULL
of	NULL
Ig	NULL
gene	NULL
rearrangements	NULL
.	NULL

Cell	NULL
,	NULL
79	NULL
,	NULL
885-892	NULL
.	NULL

Bain	NULL
,	NULL
G	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
19972	NULL
)	NULL
E2A	NULL
deficiency	NULL
leads	NULL
to	NULL
abnormalities	NULL
in	NULL
B	NULL
and	NULL
48	NULL
T	NULL
cell	NULL
development	NULL
,	NULL
perturbations	NULL
in	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
rearrangement	NULL
and	NULL
to	NULL
the	NULL
rapid	NULL
development	NULL
of	NULL
T-cell	NULL
lymphomas	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
17	NULL
,	NULL
4782-4791	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
Robanus	NULL
Maandag	NULL
,	NULL
E.	NULL
,	NULL
Te	NULL
Riele	NULL
,	NULL
H.	NULL
,	NULL
Feeney	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Shechy	NULL
,	NULL
A.	NULL
,	NULL
Schlissel	NULL
,	NULL
M.	NULL
,	NULL
Shinton	NULL
,	NULL
S.A.	NULL
,	NULL
Hardy	NULL
,	NULL
R.R	NULL
.	NULL

and	NULL
Murre	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1997b	NULL
)	NULL
Both	NULL
E12	NULL
and	NULL
E47	NULL
allow	NULL
commitment	NULL
to	NULL
the	NULL
B	NULL
cell	NULL
lineage	NULL
.	NULL

Immunity	NULL
,	NULL
6	NULL
,	NULL
145-154	NULL
.	NULL

Benezra	NULL
,	NULL
R.	NULL
,	NULL
Davis	NULL
,	NULL
Lockshon	NULL
,	NULL
D.	NULL
,	NULL
Turner	NULL
,	NULL
D.L	NULL
.	NULL

and	NULL
Weintraub	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
The	NULL
protein	NULL
Id	NULL
:	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
helix-loop-helix	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Cell	NULL
,	NULL
61	NULL
,	NULL
49-59	NULL
.	NULL

Blom	NULL
,	NULL
B.	NULL
,	NULL
Res	NULL
,	NULL
P.	NULL
,	NULL
Noteboom	NULL
,	NULL
E.	NULL
,	NULL
Weijer	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Spits	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Prethymic	NULL
CD34+*	NULL
progenitors	NULL
capable	NULL
of	NULL
developing	NULL
into	NULL
T	NULL
cells	NULL
are	NULL
not	NULL
committed	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
158	NULL
,	NULL
3571-3577	NULL
.	NULL

Blom	NULL
,	NULL
B.	NULL
,	NULL
Res	NULL
,	NULL
P.C.M	NULL
.	NULL

and	NULL
Spits	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
T	NULL
cell	NULL
precursors	NULL
in	NULL
mice	NULL
and	NULL
man	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
18	NULL
,	NULL
371-388	NULL
.	NULL

Blom	NULL
,	NULL
B.	NULL
,	NULL
Verschuren	NULL
,	NULL
M.C.M	NULL
.	NULL

,	NULL
Heemskerk	NULL
,	NULL
Bakker	NULL
,	NULL
A.Q	NULL
.	NULL

,	NULL
van	NULL
Gastel-Mol	NULL
,	NULL
E.J	NULL
,	NULL
Wolvers-Tettero	NULL
,	NULL
LL.M	NULL
.	NULL

,	NULL
van	NULL
Dongen	NULL
,	NULL
J.J.M	NULL
.	NULL

and	NULL
Spits	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
pre-T	NULL
cell	NULL
receptor	NULL
complex	NULL
during	NULL
T	NULL
cell	NULL
differentiation	NULL
.	NULL

Blood	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Breit	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
Wolvers	NULL
Tettero	NULL
,	NULL
LL	NULL
.	NULL

,	NULL
Hahlen	NULL
,	NULL
K.	NULL
,	NULL
Van	NULL
Wering	NULL
,	NULL
E.J	NULL
.	NULL

and	NULL
van	NULL
Dongen	NULL
,	NULL
J.J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Extensive	NULL
junctional	NULL
diversity	NULL
of	NULL
y8	NULL
T-cell	NULL
receptors	NULL
expressed	NULL
by	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemias	NULL
:	NULL
implications	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
minimal	NULL
residual	NULL
disease	NULL
.	NULL

Leukemia	NULL
,	NULL
5	NULL
,	NULL
1076-1086	NULL
.	NULL

Breit	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
Wolvers-Tettero	NULL
,	NULL
LL	NULL
.	NULL

,	NULL
Beishuizen	NULL
,	NULL
A.	NULL
,	NULL
Verhoeven	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Van	NULL
Wering	NULL
,	NULL
E.R	NULL
.	NULL

and	NULL
van	NULL
Dongen	NULL
,	NULL
J.J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Southern	NULL
blot	NULL
patterns	NULL
,	NULL
frequencies	NULL
,	NULL
and	NULL
junctional	NULL
diversity	NULL
of	NULL
T-cell	NULL
receptor-6	NULL
gene	NULL
rearrangements	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Blood	NULL
,	NULL
82	NULL
,	NULL
3063-3074	NULL
.	NULL

Capone	NULL
.	NULL

M.	NULL
,	NULL
Hockett	NULL
,	NULL
R.J	NULL
.	NULL

and	NULL
Zlotnik	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Kinetics	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
B	NULL
,	NULL
y	NULL
,	NULL
and	NULL
8	NULL
rearrangements	NULL
during	NULL
adult	NULL
thymic	NULL
development	NULL
:	NULL
T	NULL
cell	NULL
receptor	NULL
rearrangements	NULL
are	NULL
present	NULL
in	NULL
CD44*CD25*	NULL
pro-T	NULL
thymocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
95	NULL
,	NULL
12522-12527	NULL
.	NULL

Christy	NULL
,	NULL
B.A	NULL
.	NULL

,	NULL
Sanders	NULL
,	NULL
L.K	NULL
.	NULL

,	NULL
Lau	NULL
,	NULL
L.F.	NULL
,	NULL
Copeland	NULL
,	NULL
Jenkins	NULL
,	NULL
N.A	NULL
.	NULL

and	NULL
Nathans	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
An	NULL
Id-related	NULL
helix-loop-helix	NULL
protein	NULL
encoded	NULL
by	NULL
a	NULL
growth	NULL
factor-inducible	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
1815-1819	NULL
.	NULL

Church	NULL
,	NULL
G.M	NULL
.	NULL

,	NULL
Ephrussi	NULL
,	NULL
A.	NULL
,	NULL
Gilbert	NULL
,	NULL
W.	NULL
and	NULL
Tonegawa	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cell-type-specific	NULL
contacts	NULL
to	NULL
immunoglobulin	NULL
enhancers	NULL
in	NULL
nuclei	NULL
.	NULL

Nature	NULL
,	NULL
313	NULL
,	NULL
798-801	NULL
.	NULL

Davies	NULL
,	NULL
M.V	NULL
.	NULL

and	NULL
Kaufman	NULL
,	NULL
R.J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
The	NULL
sequence	NULL
context	NULL
of	NULL
the	NULL
initiation	NULL
codon	NULL
in	NULL
the	NULL
encephalomyocarditis	NULL
virus	NULL
leader	NULL
modulates	NULL
efficiency	NULL
of	NULL
internal	NULL
translation	NULL
initiation	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
66	NULL
,	NULL
1924-1932	NULL
.	NULL

Donskoy	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Goldschneider	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Thymocytopoiesis	NULL
is	NULL
maintained	NULL
by	NULL
blood-borne	NULL
precursors	NULL
throughout	NULL
postnatal	NULL
life	NULL
.	NULL

A	NULL
study	NULL
in	NULL
parabiotic	NULL
mice	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
148	NULL
,	NULL
1604-1612	NULL
.	NULL

Ephrussi	NULL
,	NULL
A.	NULL
,	NULL
Church	NULL
,	NULL
G.M	NULL
.	NULL

,	NULL
Tonegawa	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Gilbert	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
B	NULL
lineage-specific	NULL
interactions	NULL
of	NULL
an	NULL
immunoglobulin	NULL
enhancer	NULL
with	NULL
cellular	NULL
factors	NULL
in	NULL
vivo	NULL
.	NULL

Science	NULL
,	NULL
227	NULL
,	NULL
134-140	NULL
.	NULL

Fehling	NULL
,	NULL
H.J	NULL
.	NULL

,	NULL
Krotkova	NULL
,	NULL
A.	NULL
,	NULL
Saint	NULL
Ruf	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Von	NULL
Bochmer	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Crucial	NULL
role	NULL
of	NULL
the	NULL
pre-T-cell	NULL
receptor	NULL
@	NULL
gene	NULL
in	NULL
development	NULL
of	NULL
(	NULL
B	NULL
but	NULL
not	NULL
y6	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
,	NULL
375	NULL
,	NULL
795-798	NULL
.	NULL

Galy	NULL
,	NULL
A.	NULL
,	NULL
Verma	NULL
,	NULL
S.	NULL
,	NULL
Barcena	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Spits	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Precursors	NULL
of	NULL
CD3*CD4*CD8*	NULL
cells	NULL
in	NULL
the	NULL
human	NULL
thymus	NULL
are	NULL
defined	NULL
by	NULL
expression	NULL
of	NULL
CD34	NULL
.	NULL

Delineation	NULL
of	NULL
early	NULL
events	NULL
in	NULL
human	NULL
thymic	NULL
development	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
178	NULL
,	NULL
391-401	NULL
.	NULL

Godfrey	NULL
,	NULL
D.I	NULL
.	NULL

and	NULL
Zlotnik	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Control	NULL
points	NULL
in	NULL
early	NULL
T-cell	NULL
development	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
,	NULL
14	NULL
,	NULL
547-553	NULL
.	NULL

Hanenberg	NULL
,	NULL
H.	NULL
,	NULL
Xiao	NULL
,	NULL
Dilloo	NULL
,	NULL
D.	NULL
,	NULL
Hashino	NULL
,	NULL
K.	NULL
,	NULL
Kato	NULL
,	NULL
I	NULL
.	NULL

and	NULL
Williams	NULL
,	NULL
D.A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Colocalization	NULL
of	NULL
retrovirus	NULL
and	NULL
target	NULL
cells	NULL
on	NULL
specific	NULL
fibronectin	NULL
fragments	NULL
increases	NULL
genetic	NULL
transduction	NULL
of	NULL
mammalian	NULL
cells	NULL
.	NULL

Nature	NULL
Med	NULL
.	NULL

,	NULL
2	NULL
,	NULL
876-882	NULL
.	NULL

Hanenberg	NULL
,	NULL
H.	NULL
,	NULL
Hashino	NULL
,	NULL
K.	NULL
,	NULL
Konishi	NULL
,	NULL
H.	NULL
,	NULL
Hock	NULL
,	NULL
R.A.	NULL
,	NULL
Kato	NULL
,	NULL
I	NULL
.	NULL

and	NULL
Williams	NULL
,	NULL
D.A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Optimization	NULL
of	NULL
fibronectin-assisted	NULL
retroviral	NULL
gene	NULL
transfer	NULL
into	NULL
human	NULL
CD34*	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Human	NULL
Gene	NULL
Ther	NULL
,	NULL
8	NULL
,	NULL
2193-2206	NULL
.	NULL

Heemskerk	NULL
,	NULL
M.H.M	NULL
.	NULL

,	NULL
Blom	NULL
,	NULL
B.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
,	NULL
Stegmann	NULL
,	NULL
A.P.A	NULL
.	NULL

,	NULL
Bakker	NULL
,	NULL
A.Q	NULL
.	NULL

,	NULL
Weijer	NULL
,	NULL
K.	NULL
,	NULL
Res	NULL
,	NULL
P.C.M	NULL
.	NULL

and	NULL
Spits	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Inhibition	NULL
of	NULL
T	NULL
cell	NULL
and	NULL
promotion	NULL
of	NULL
natural	NULL
killer	NULL
cell	NULL
development	NULL
by	NULL
the	NULL
dominant	NULL
negative	NULL
helix-loop-helix	NULL
factor	NULL
Id3	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
186	NULL
,	NULL
1597-1602	NULL
.	NULL

2801	NULL
B.Blom	NULL
et	NULL
al	NULL
.	NULL

Jaleco	NULL
,	NULL
A.C.	NULL
,	NULL
Blom	NULL
,	NULL
B.	NULL
,	NULL
Res	NULL
,	NULL
P.	NULL
,	NULL
Weijer	NULL
,	NULL
K.	NULL
,	NULL
Lanier	NULL
,	NULL
L.L	NULL
.	NULL

,	NULL
Phillips	NULL
,	NULL
J.H	NULL
.	NULL

and	NULL
Spits	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Fetal	NULL
liver	NULL
contains	NULL
committed	NULL
NK	NULL
progenitors	NULL
,	NULL
but	NULL
is	NULL
not	NULL
a	NULL
site	NULL
for	NULL
development	NULL
of	NULL
CD34*	NULL
cells	NULL
into	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
159	NULL
,	NULL
694-702	NULL
.	NULL

Kang	NULL
,	NULL
J.	NULL
,	NULL
Baker	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Raulet	NULL
,	NULL
D.H	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Evidence	NULL
that	NULL
productive	NULL
rearrangements	NULL
of	NULL
TCR	NULL
y	NULL
genes	NULL
influence	NULL
the	NULL
commitment	NULL
of	NULL
progenitor	NULL
cells	NULL
to	NULL
differentiate	NULL
into	NULL
B	NULL
or	NULL
45	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
25	NULL
,	NULL
2706-2709	NULL
.	NULL

Kimizuka	NULL
,	NULL
F.	NULL
,	NULL
Taguchi	NULL
,	NULL
Y.	NULL
,	NULL
Ohdate	NULL
,	NULL
Y.	NULL
,	NULL
Kawase	NULL
,	NULL
Y.	NULL
,	NULL
Shimojo	NULL
,	NULL
T.	NULL
,	NULL
Hashino	NULL
,	NULL
K.	NULL
,	NULL
Kato	NULL
,	NULL
L	NULL
,	NULL
Sekiguchi	NULL
,	NULL
K	NULL
.	NULL

and	NULL
TitaniK	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Production	NULL
and	NULL
characterization	NULL
of	NULL
functional	NULL
domains	NULL
of	NULL
human	NULL
fibronectin	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

(	NULL
Tokyo	NULL
)	NULL
,	NULL
110	NULL
,	NULL
284-291	NULL
.	NULL

Kinsella	NULL
,	NULL
and	NULL
Nolan	NULL
,	NULL
G.P	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Episomal	NULL
vectors	NULL
rapidly	NULL
and	NULL
stably	NULL
produce	NULL
high-titer	NULL
recombinant	NULL
retrovirus	NULL
.	NULL

Human	NULL
Gene	NULL
Ther	NULL
,	NULL
7	NULL
,	NULL
1405-1413	NULL
.	NULL

Kraft	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
Weissman	NULL
,	NULL
LL	NULL
.	NULL

and	NULL
WallerEK	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Differentiation	NULL
of	NULL
CD3	NULL
4~8~	NULL
human	NULL
fetal	NULL
thymocytes	NULL
in	NULL
vivo	NULL
:	NULL
characterization	NULL
of	NULL
a	NULL
CD3~	NULL
4*8~	NULL
intermediate	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
178	NULL
,	NULL
265-277	NULL
.	NULL

Krangel	NULL
,	NULL
M.S	NULL
.	NULL

,	NULL
Yssel	NULL
,	NULL
H.	NULL
,	NULL
Brocklehurst	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Spits	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
A	NULL
distinct	NULL
wave	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
y5	NULL
lymphocytes	NULL
in	NULL
the	NULL
early	NULL
fetal	NULL
thymus	NULL
:	NULL
evidence	NULL
for	NULL
controlled	NULL
gene	NULL
rearrangement	NULL
and	NULL
cytokine	NULL
production	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
172	NULL
,	NULL
847-859	NULL
.	NULL

Livak	NULL
,	NULL
E.	NULL
,	NULL
Petric	NULL
,	NULL
H.T	NULL
.	NULL

,	NULL
Crispe	NULL
,	NULL
LN	NULL
.	NULL

and	NULL
Schatz	NULL
,	NULL
D.G	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
In-frame	NULL
TCR	NULL
8	NULL
gene	NULL
rearrangements	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
decision	NULL
.	NULL

Immunity	NULL
,	NULL
2	NULL
,	NULL
617-627	NULL
Loveys	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
Streiff	NULL
M.B	NULL
.	NULL

and	NULL
Kato	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
EZ2A	NULL
basic-helix-loop-helix	NULL
transcription	NULL
factors	NULL
are	NULL
negatively	NULL
regulated	NULL
by	NULL
serum	NULL
growth	NULL
factors	NULL
and	NULL
by	NULL
the	NULL
Id3	NULL
protein	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
24	NULL
,	NULL
2813-2820	NULL
.	NULL

Margolis	NULL
,	NULL
D.	NULL
,	NULL
Yassai	NULL
,	NULL
M.	NULL
,	NULL
Hletko	NULL
,	NULL
A.	NULL
,	NULL
McOlash	NULL
,	NULL
L	NULL
.	NULL

and	NULL
Gorski	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Concurrent	NULL
or	NULL
sequential	NULL
delta	NULL
and	NULL
beta	NULL
TCR	NULL
gene	NULL
rearrangement	NULL
during	NULL
thymocyte	NULL
development	NULL
:	NULL
individual	NULL
thymi	NULL
follow	NULL
distinct	NULL
pathways	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
159	NULL
,	NULL
529-533	NULL
Marquez	NULL
,	NULL
C.	NULL
,	NULL
Trigueros	NULL
,	NULL
C.	NULL
,	NULL
Fernandez	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Toribio	NULL
,	NULL
M.L	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
The	NULL
development	NULL
of	NULL
T	NULL
and	NULL
non-T	NULL
cell	NULL
lineages	NULL
from	NULL
CD34*	NULL
human	NULL
thymic	NULL
precursors	NULL
can	NULL
be	NULL
traced	NULL
by	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
CD44	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
181	NULL
,	NULL
475-483	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
McCaw	NULL
,	NULL
P.S	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
motif	NULL
in	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
,	NULL
daughterless	NULL
,	NULL
MyoD	NULL
,	NULL
and	NULL
myc	NULL
proteins	NULL
.	NULL

Cell	NULL
,	NULL
56	NULL
,	NULL
777-783	NULL
.	NULL

Murre	NULL
,	NULL
C	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Structure	NULL
and	NULL
function	NULL
of	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1218	NULL
,	NULL
129-135	NULL
.	NULL

Pestova	NULL
,	NULL
T.V	NULL
.	NULL

,	NULL
Hellen	NULL
,	NULL
C.U	NULL
.	NULL

and	NULL
Shatsky	NULL
,	NULL
LN	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Canonical	NULL
eukaryotic	NULL
initiation	NULL
factors	NULL
determine	NULL
initiation	NULL
of	NULL
translation	NULL
by	NULL
internal	NULL
ribosomal	NULL
entry	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
6859-6869	NULL
.	NULL

Ramiro	NULL
,	NULL
A.R	NULL
.	NULL

,	NULL
Trigueros	NULL
,	NULL
C.	NULL
,	NULL
Marquez	NULL
,	NULL
C.	NULL
,	NULL
San	NULL
,	NULL
M.J	NULL
.	NULL

and	NULL
Toribio	NULL
,	NULL
M.L	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Regulation	NULL
of	NULL
pre-T	NULL
cell	NULL
receptor	NULL
(	NULL
pTo-TCRB	NULL
)	NULL
gene	NULL
expression	NULL
during	NULL
human	NULL
thymic	NULL
development	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
184	NULL
,	NULL
519-530	NULL
.	NULL

Res	NULL
,	NULL
P.	NULL
,	NULL
Martinez	NULL
Caceres	NULL
,	NULL
E.	NULL
,	NULL
Jaleco	NULL
,	NULL
A.C.	NULL
,	NULL
Noteboom	NULL
,	NULL
E.	NULL
,	NULL
Weijer	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Spits.H	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
CD34*CD38	NULL
``	NULL
``	NULL
cells	NULL
in	NULL
the	NULL
human	NULL
thymus	NULL
can	NULL
differentiate	NULL
into	NULL
T	NULL
,	NULL
natural	NULL
killer	NULL
and	NULL
dendritic	NULL
cells	NULL
but	NULL
are	NULL
distinct	NULL
from	NULL
stem	NULL
cells	NULL
.	NULL

Blood	NULL
,	NULL
87	NULL
,	NULL
5196-5206	NULL
Res	NULL
,	NULL
P.	NULL
,	NULL
Blom	NULL
,	NULL
B.	NULL
,	NULL
Hori	NULL
,	NULL
T.	NULL
,	NULL
Weijer	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Spits	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Downregulation	NULL
of	NULL
CD1	NULL
marks	NULL
acquisition	NULL
of	NULL
functional	NULL
maturation	NULL
of	NULL
human	NULL
thymocytes	NULL
and	NULL
defines	NULL
a	NULL
control	NULL
point	NULL
in	NULL
late	NULL
stages	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
185	NULL
,	NULL
141-151	NULL
.	NULL

Riechmann	NULL
,	NULL
V.	NULL
,	NULL
Van	NULL
Cruchten	NULL
,	NULL
I	NULL
.	NULL

and	NULL
Sablitzky	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
The	NULL
expression	NULL
pattern	NULL
of	NULL
Id4	NULL
,	NULL
a	NULL
novel	NULL
dominant	NULL
negative	NULL
helix-loop-helix	NULL
protein	NULL
,	NULL
is	NULL
distinct	NULL
from	NULL
Id1	NULL
,	NULL
Id2	NULL
and	NULL
Id3	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
22	NULL
,	NULL
749-755	NULL
.	NULL

Sachs	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
Sarnow	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Hentze	NULL
,	NULL
M.W	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Starting	NULL
at	NULL
the	NULL
beginning	NULL
,	NULL
middle	NULL
,	NULL
and	NULL
end	NULL
:	NULL
translation	NULL
initiation	NULL
in	NULL
eukaryotes	NULL
.	NULL

Cell	NULL
,	NULL
89	NULL
,	NULL
831-838	NULL
.	NULL

Sanchez	NULL
,	NULL
M.J.	NULL
,	NULL
Spits	NULL
,	NULL
H.	NULL
,	NULL
Lanier	NULL
,	NULL
LL	NULL
.	NULL

and	NULL
Philips	NULL
,	NULL
J.H	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Human	NULL
natural	NULL
killer	NULL
cell	NULL
committed	NULL
thymocytes	NULL
and	NULL
their	NULL
relationship	NULL
to	NULL
the	NULL
,	NULL
T	NULL
cell	NULL
lineage	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
178	NULL
,	NULL
1857-1866	NULL
.	NULL

Sanchez	NULL
,	NULL
M.-J	NULL
.	NULL

,	NULL
-	NULL
Muench	NULL
,	NULL
M.0	NULL
.	NULL

,	NULL
-	NULL
Roncarolo	NULL
,	NULL
M.G	NULL
.	NULL

,	NULL
Lanien	NULL
,	NULL
L	NULL
.	NULL

-	NULL
and	NULL
Phillips	NULL
,	NULL
J.H	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Identification	NULL
of	NULL
a	NULL
common	NULL
T/NK	NULL
cell	NULL
progenitor	NULL
in	NULL
human	NULL
fetal	NULL
thymus	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
180	NULL
,	NULL
569-576	NULL
.	NULL

Scollay	NULL
,	NULL
R.	NULL
,	NULL
Smith	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Stauffer	NULL
,	NULL
V	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Dynamics	NULL
of	NULL
early	NULL
T	NULL
cells	NULL
:	NULL
prothymocyte	NULL
migration	NULL
and	NULL
proliferation	NULL
in	NULL
the	NULL
adult	NULL
mouse	NULL
thymus	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

,	NULL
91	NULL
,	NULL
129-157	NULL
.	NULL

Shortman	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Wu	NULL
,	NULL
L	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Early	NULL
T	NULL
lymphocyte	NULL
progenitors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
29-47	NULL
.	NULL

Sigvardsson	NULL
,	NULL
M.	NULL
,	NULL
O'Riordan	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Grosschedl	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
EBF	NULL
and	NULL
E47	NULL
collaborate	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
immunoglobulin	NULL
surrogate	NULL
light	NULL
chain	NULL
genes	NULL
.	NULL

Immunity	NULL
,	NULL
7	NULL
,	NULL
25-36	NULL
.	NULL

Spits	NULL
,	NULL
H.	NULL
,	NULL
Lanier	NULL
,	NULL
L	NULL
.	NULL

and	NULL
Phillips	NULL
,	NULL
J.H	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Development	NULL
of	NULL
human	NULL
T	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Blood	NULL
,	NULL
85	NULL
,	NULL
2654-2670	NULL
.	NULL

2802	NULL
Spits	NULL
,	NULL
H.	NULL
,	NULL
Blom	NULL
,	NULL
B.	NULL
,	NULL
Jaleco	NULL
,	NULL
A.C.	NULL
,	NULL
Weijer	NULL
,	NULL
K.	NULL
,	NULL
Verschuren	NULL
,	NULL
M.C.M	NULL
,	NULL
van	NULL
Dongen	NULL
,	NULL
J.J.	NULL
,	NULL
Heemskerk	NULL
,	NULL
M.H.M	NULL
and	NULL
Res	NULL
,	NULL
P.C.M	NULL
(	NULL
1998	NULL
)	NULL
Early	NULL
stages	NULL
in	NULL
the	NULL
development	NULL
of	NULL
human	NULL
T	NULL
,	NULL
natural	NULL
killer	NULL
and	NULL
thymic	NULL
dendritic	NULL
cells	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

,	NULL
165	NULL
,	NULL
75-86	NULL
.	NULL

Sun	NULL
,	NULL
X.H	NULL
.	NULL

,	NULL
Copeland	NULL
,	NULL
N.G	NULL
.	NULL

,	NULL
Jenkins	NULL
,	NULL
N.A	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Id	NULL
proteins	NULL
Id1	NULL
and	NULL
Id2	NULL
selectively	NULL
inhibit	NULL
DNA	NULL
binding	NULL
by	NULL
one	NULL
class	NULL
of	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
,	NULL
5603-5611	NULL
.	NULL

Verschuren	NULL
,	NULL
M.C.M	NULL
.	NULL

,	NULL
Blom	NULL
,	NULL
B.	NULL
,	NULL
Spits	NULL
,	NULL
H	NULL
.	NULL

and	NULL
van	NULL
Dongen	NULL
,	NULL
J.J.M	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
PjA-Bp	NULL
expression	NULL
and	NULL
T	NULL
cell	NULL
receptor	NULL
8	NULL
deletion	NULL
during	NULL
human	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
10	NULL
,	NULL
1873-1880	NULL
.	NULL

Washbum	NULL
,	NULL
T.	NULL
,	NULL
Schweighoffer	NULL
,	NULL
E.	NULL
,	NULL
Gridley	NULL
,	NULL
,	NULL
Chang	NULL
,	NULL
D.	NULL
,	NULL
Fowlkes	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
Cado	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Robey	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Notch	NULL
activity	NULL
influences	NULL
the	NULL
f	NULL
versus	NULL
48	NULL
T	NULL
cell	NULL
lineage	NULL
decision	NULL
.	NULL

Cell	NULL
,	NULL
88	NULL
,	NULL
833-843	NULL
.	NULL

Yssel	NULL
,	NULL
H.	NULL
,	NULL
De	NULL
Vries	NULL
,	NULL
J.E	NULL
.	NULL

,	NULL
Koken	NULL
,	NULL
M.	NULL
,	NULL
Van	NULL
Blitterswijk	NULL
,	NULL
W	NULL
.	NULL

and	NULL
Spits	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Serum-free	NULL
medium	NULL
for	NULL
the	NULL
generation	NULL
and	NULL
the	NULL
propagation	NULL
of	NULL
functional	NULL
human	NULL
cytotoxic	NULL
and	NULL
helper	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
,	NULL
72	NULL
,	NULL
219-227	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
Soriano	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Weintraub	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
The	NULL
helix-loop-helix	NULL
gene	NULL
E2A	NULL
is	NULL
required	NULL
for	NULL
B	NULL
cell	NULL
formation	NULL
.	NULL

Cell	NULL
,	NULL
79	NULL
,	NULL
875-884	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
Cheng	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Weintraub	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
B	NULL
lymphocyte	NULL
development	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
combined	NULL
dosage	NULL
of	NULL
three	NULL
basic-helix-loop-helix	NULL
genes	NULL
,	NULL
E2A	NULL
,	NULL
E2-2	NULL
and	NULL
HEB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
2898-2905	NULL
.	NULL

Received	NULL
October	NULL
2	NULL
,	NULL
1998	NULL
;	NULL
revised	NULL
and	NULL
accepted	NULL
March	NULL
18	NULL
,	NULL
1999	NULL

